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Summary 39 
The function of somatic stem cells declines with age. Understanding the molecular 40 
underpinnings of this decline is key to counteract age-related disease. Here, we report 41 
a dramatic drop in the neural stem cells (NSCs) number in the aging murine brain. We 42 
find that this smaller stem cell reservoir is protected from full depletion by an increase 43 
in quiescence that makes old NSCs more resistant to regenerate the injured brain. 44 
Once activated, however, young and old NSCs show similar proliferation and 45 
differentiation capacity. Single cell transcriptomics of NSCs indicated that aging 46 
changes NSCs minimally. In the aging brain niche-derived inflammatory signals and 47 
the Wnt antagonist sFRP5 induce quiescence. Indeed, intervention to neutralize them 48 
increased activation of old NSCs during homeostasis and following injury. Our study 49 
identifies quiescence as key feature of old NSCs imposed by the niche and uncovers 50 
ways to activate NSCs to repair the aging brain.  51 
Key words: 52 
Stem cell aging, neural stem cells, Quiescence, Inflammation, Wnt Signaling, single 53 
cell transcriptomics, modeling, simulations, interferon, sFRP5, subventricular zone. 54 
Introduction 55 
In the adult murine brain, NSCs residing within the ventricular-subventricular zone 56 
(V-SVZ) of the lateral ventricles generate olfactory bulb (OB) interneurons required 57 
to fine-tune odor discrimination throughout the life of the animal. Recent studies have 58 
characterized the division mode and the transcriptional programs underlying the 59 
different activation states of NSCs in the young brain. Yet, whether this default 60 
program is affected by age and how this potentially influences NSC function is 61 
controversial. In the old brain NSCs retain the ability to generate the different 62 
subtypes of OB interneurons, albeit at much lower numbers (Basak et al., 2018; 63 
Dulken et al., 2017; Llorens-Bobadilla et al., 2015; Obernier et al., 2018; Shook et al., 64 
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2012). Whereas some studies report a decreased proliferation of NSCs (Capilla-65 
Gonzalez et al., 2014; Shi et al., 2017; Silva-Vargas et al., 2016), others report no 66 
changes or even an increase in proliferation (Ahlenius et al., 2009; Shook et al., 67 
2012). In the human brain, generation of new neurons is debated (Kempermann et al., 68 
2018). In the adult human brain C14 birth dating studies have revealed the existence 69 
of new neurons in the striatum, and the V-SVZ NSCs are regarded as the source of 70 
these striatal interneurons (Ernst et al., 2014).  71 
The present study addresses the stem cell dynamics within the V-SVZ throughout the 72 
life of the animal. Mathematical modelling is used to explore how time-dependent 73 
changes in key stem cell features can explain the age-dependent decline of the NSC 74 
pool. Profiling of the single transcriptomes of young and aged NSCs and of the 75 
transcriptomes of neighboring niche cells is used to identify drivers of this age-76 
dependent changes. Altogether, this study advances our understanding of the 77 
molecular underpinnings of age-related decline in NSC function.  78 
Results 79 
A time-dependent increase in quiescence maintains a stem cell reservoir at old 80 
age while making stem cells more resistant to activation 81 
To assess age-related changes of NSCs, we quantified the numbers of NSCs and their 82 
immediate progeny across different ages. To this end, we performed FACS analysis 83 
of different cell subpopulations isolated from the V-SVZ of 2, 7 and 22 months old 84 
(MO) mice (Fig.1Α, S6A). This analysis revealed that the total number of NSCs 85 
significantly declines between 2 and 7 MO and remains low at 22 MO. We further 86 
analyzed the numbers of quiescent NSCs (qNSCs), active NSCs (aNSCs) and transit 87 
amplifying progenitors (TAPs). All three populations showed similar dynamics, with 88 
a significant decrease from 2 to 7 MO, and low numbers from 7 to 22 MO. To 89 
confirm this observation, we quantified NSCs and their progeny within the V-SVZ in 90 
situ. The TLX-CreERT2YFP reporter mouse line was used to label NSCs (Liu et al., 91 
2010). To additionally identify progenitors that became quiescent at embryonic day 92 
14 (E14) and only got reactivated in the adult V-SVZ (Fuentealba et al., 2015), we 93 
administered BrdU at E14. Note that every labeling protocol used in this study can be 94 
found in Fig.S5A. The number of embryonic-label retaining NSCs (E-LRCs) 95 
drastically decreased between 2 and 14 MO (Fig.1B,C). Together, these data show a 96 
rapid decline of the number of NSCs from 2 to 7 MO that slows down thereafter.  97 
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Others had reported this age-dependent decrease of NSC number, however the NSC 98 
features that have to change with time to explain this decline had not been addressed. 99 
To this end, we built a mathematical model (MM) of V-SVZ NSC dynamics (Data 100 
S1), based on a mathematical framework developed to describe adult hippocampal 101 
neurogenesis (Ziebell et al., 2018; 2014). For model fitting we considered a joint data 102 
set consisting of the subset of the frequency of active cells as a fraction of the adult 103 
label-retaining cells (LRCs- 14d BrdU administration in drinking water followed by 104 
14d of chase time before sacrificing the animals at indicated ages; Fig.S5) and of the 105 
subset of active cells as a fraction of the TLX labeled cells (Fig.S1A-D, S5). We fitted 106 
the model using both subsets simultaneously. Based on our own experimental data 107 
and current literature (Basak et al., 2018; Obernier et al., 2018) we assumed that 108 
qNSCs can enter cell cycle to become aNSCs and give rise to either two qNSCs or 109 
two TAPs with the capacity of performing n symmetric self-renewing divisions 110 
(Fig.1D). This is different to the assumptions we used in our previous work on NSC 111 
dynamics in the hippocampus, where we allowed additional NSC fates, like 112 
asymmetric divisions or depletion through cell death or direct transformation into 113 
astrocytes (Ziebell et al., 2014; 2018).  114 
First, we designed a model with cell parameters that do not change in time and 115 
evaluated its outcome by comparing it to experimental data. The assumption of time-116 
constant parameters, called “no-aging” scenario, led to an exponential decay of the 117 
total NSC number, which did not match the experimental observation of saturation of 118 
the decline of NSC numbers at an older age (Fig.1E, left panel). Furthermore, 119 
contrary to the experimental data, the model with this assumption predicted that the 120 
fraction of active among all LRCs and TLX-labeled cells would not change over time 121 
(Fig.1E, right panel). To identify mechanisms that might explain the observed decline 122 
in the fraction of the active cells, we considered three age-dependent scenarios: 123 
increase in cell-cycle length; increase in self-renewal; and increase of the mean time 124 
spent in quiescence (Fig.1F-H, Data S1). To compare model predictions to 125 
experimental data, we examined the following time-dependent quantities: number of 126 
NSCs, and fraction of active among adult LRCs and TLX-labeled cells. 127 
We first assumed, as previously suggested by (Daynac et al., 2016), that upon aging 128 
aNSCs require progressively more time to complete their cell cycle (without taking in 129 
account time in G0 phase). As in the no-aging scenario, this led to dynamics with 130 
faster depletion of the total number of NSCs (Fig.1F, left panel) and time-constant 131 
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fraction of aNSCs (Fig.1F, right panel). In the second scenario, we modeled an age-132 
related increase of the fraction of self-renewal, i.e., assuming that upon aging a higher 133 
fraction of aNSCs divisions results in two qNSCs rather than two TAPs. This model 134 
correctly reproduced the saturation in the decay of the total number of NSCs (Fig.1G, 135 
left panel) but showed only a 3.5% decline in the fraction of aNSCs in contrast to the 136 
37% decline observed in the experimental data and it would require a low fraction of 137 
aNSCs in young mice (Fig.1G, right panel).  In addition, the model predicted a rapid 138 
decline in the number of NSCs at young age, which would require a much larger 139 
number of cells (1.1×10^6 cells) at the beginning of the process (Fig.S1E). Finally, 140 
we assumed that the time NSCs spend in quiescence (G0) increases with age.  141 
Changes in this feature fit the experimental data best, since they are not only showing 142 
the saturation of the decline in total NSC numbers (Fig.1H, left panel), but also the 143 
drop in the fraction of aNSCs (35% in the model simulation vs. 37% in the data) 144 
(Fig.1H, right panel). The conclusion that only the increasing quiescence scenario can 145 
explain the data is supported by the Akaike information criterion (AIC); (Data S1-146 
Tables 1-3). To further validate our results, we considered a model with two time-147 
dependent cell parameters accounting for both, simultaneous increase of the fraction 148 
of NSC self-renewal and increase of the mean time spent by a cell in quiescence. 149 
Although increasing the number of free parameters allows finding a fit that seems 150 
closer to the data, the model combining two time-dependent parameters was not 151 
superior in terms of AIC. To quantify the contribution of changes of both factors to 152 
the optimal fit, we extracted the dynamics of the two parameters from the model 153 
(Fig.S1F and Data S1-Tables 1-3). Comparison of the estimated cell properties in the 154 
different models showed that even if the two parameters undergo age-dependent 155 
changes, the major component of the regulatory process that explains the observed 156 
dynamics, is the increase in time spent in quiescence (decreasing rate of activation 157 
from quiescence). This prediction was experimentally validated by the significant 158 
decrease of the percentage of aNSCs among E-LRCs between 2, 7 and 14 MO (Fig.1I, 159 
S1G). Altogether, these data show, that during homeostasis the fraction of NSCs in 160 
quiescence increases with age. 161 
We next asked if qNSCs are equally able to become activated upon injury in the 162 
young and old brain. To this end we ablated cycling cells including aNSCs, TAPs and 163 
NBs using temozolomide (TMZ), a DNA-alkylating agent (Fig.2A). This ablation 164 
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activates qNSCs to replenish the NSC compartment (Mich et al., 2014). Proliferation 165 
of V-SVZ NSCs in 2 and 22 MO mice was assessed by a 2-hour BrdU labeling 166 
protocol at 0, 1, 9 and 35 days following TMZ treatment (Fig.S2A, S5). 35 days 167 
following TMZ treatment, the number of aNSCs rose again to about the same level as 168 
before (92% of the cell number after the control treatment; CI95:67%-117%) in 169 
young mice, while only 44% (CI95:37%-51%; p=2.7*10^-5) of the control level was 170 
achieved in old mice (CI95=95% confidence interval according to Student's t-test) 171 
(Fig.2B). Hence, old qNSCs are more resistant to injury-induced activation and thus 172 
unable to quickly repair the old brain. 173 
Young and old NSCs are functionally and molecularly similar  174 
We next set out to address the factors involved in the NSCs’ resistance to enter the 175 
activation state. DNA damage increases upon aging in several stem cell compartments 176 
(Oh et al., 2014), potentially compromising their function. This is the case for 177 
quiescent hematopoietic stem cells (HSCs) that exhibit DNA damage upon repeated 178 
activation, as assessed by the alkaline comet assay (Walter et al., 2015). However, the 179 
comet assay on freshly sorted qNSCs and aNSCs from young and old mice revealed 180 
no major differences in the levels of DNA damage (Fig.S2B,C, S6). We next tested if 181 
once activated, old and young NSCs would perform different. To this end, we 182 
recorded the cell dynamics of freshly sorted active NSCs from 2 and 22 MO mice via 183 
time-lapse video microscopy for a period of 6 days and reconstructed their lineage 184 
trees (Fig.2C, S2D). In the absence of growth factors or other extrinsic signals, aNSCs 185 
follow their in vivo fate allowing evaluation of parameters such as clone size, rounds 186 
of division and average cell cycle length (Ortega et al., 2013). After several rounds of 187 
division, both young and old aNSCs gave rise to neuroblasts (NBs) demonstrating 188 
their neurogenic potential (Fig.2C); both young and old aNSCs generated clones of 189 
similar size (Fig.2D), underwent similar number of division rounds (Fig.2E) and 190 
exhibited similar average cell cycle length (Fig.2F). In addition, freshly sorted aNSCs 191 
from 2, 7 and 22 MO mice exhibited similar self-renewal capacity as assessed by an 192 
in vitro sphere assay (Fig.S2E,F). Altogether, these results show that once activated, 193 
old NSCs perform as well as their younger counterparts. 194 
We then investigated the molecular underpinnings of age-induced quiescence using 195 
single cell transcriptomics data of 92 NSCs from 2 MO mice and 133 NSCs from 23 196 
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MO mice. These NSCs were sequenced using the Smart-seq2 protocol. Our analysis 197 
on NSCs from young mice has already been published (Llorens-Bobadilla et al., 198 
2015) (Fig.S6A). Here we used additional libraries from old mice that had also been 199 
prepared in the context of our previous study but not discussed there. When including 200 
these, hierarchical clustering identified the four different activation states of NSCs 201 
(qNSC1, qNSC2, aNSC1, aNSC2) that we had previously reported (Table S1) 202 
(Llorens-Bobadilla et al., 2015). Interestingly, principal component analysis revealed 203 
that the activation state and not the age is the dominant source of difference 204 
(Fig.3A,B). This result also confirms that there are at most only minimal batch effects 205 
between the young and the old data set. Notably, the proportion of qNSCs was much 206 
higher among NSCs from old mice than in those from young mice (Fig.3C). 207 
Interestingly, the expression of DNA repair-related genes was higher in aNSCs vs 208 
qNSCs irrespective of age (Fig.3D). To ensure that the much higher number of 209 
qNSC1 is not due to contaminating astrocytes, we additionally sequenced cortical and 210 
striatal astrocytes from old mice. We found many differentially expressed (DE) genes 211 
between astrocytes and qNSC1. Among them CD9, a marker previously shown to be 212 
higher expressed in NSCs than in astrocytes (Llorens-Bobadilla et al., 2015) 213 
(Fig.3E,F, Table S2). These data suggest that the increased number of cells within the 214 
qNSC1 cluster is not due to mis-labeling of contaminating astrocytes but to a higher 215 
number of bona-fide qNSC1 profiles in the aging brain.  216 
To sequence a higher number of cells, we used the Chromium Single Cell 3’ platform 217 
from 10x Genomics (sequenced libraries were produced in an identical manner). To 218 
this end, we profiled a GLAST+ fraction of V-SVZ cells enriched for NSCs from 2 219 
and 22 MO mice (Fig.S6B). 1696 young and 1370 old cells passed the quality control 220 
and were used for further analysis (Table S4). 9 different clusters were identified 221 
using the Seurat package (Fig.4A). We used genes expressed specifically in each 222 
cluster to assign them as qNSCs (qNSC1, qNSC2), aNSCs (aNSC0, aNSC1, aNSC2), 223 
TAPs, NBs, oligodendrocytes (ODs) and oligodendrocyte progenitors (OPCs) 224 
according to previously published classification (Basak et al., 2018; Dulken et al., 225 
2017; Llorens-Bobadilla et al., 2015) (Fig.4A, Table S1). Complementary to the 226 
clustering analysis by Seurat, we used Monocle 2 to assign a linear “pseudotime” 227 
ordering to the cells (excluding ODs and OPCs). This analysis confirmed the same 228 
lineage progression from qNSCs1 qNSCs2 aNSCs0 aNSCs1 aNSCs2 229 
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TAPs NBs for old and young NSCs (Fig.4B, S3A). The tSNE plot gives the 230 
impression of a disconnection between qNSC1 and the rest of the continuum of 231 
neurogenesis; this, however, might be an artifact of the t-SNE projection. To test this, 232 
we inspected the distribution of Euclidean distances between cells within the qNSC1 233 
and qNSC2 clusters and found them to be comparable to the qNSC2—aNSC0 234 
distances but substantially lower than distances between distantly related clusters like 235 
qNSC1—mature ODs (Fig.S3B). As previously observed in young NSCs, lineage 236 
transitions were accompanied by a continuous gradient of expression changes 237 
between the different stages (Fig.S3C,D, Table S1). Altogether, comparison of young 238 
and old NSCs showed that they share the same activation states and proceed along the 239 
same lineage.  240 
Surprisingly, only the activation state, but not the age of the cells dictated their 241 
segregation to the different clusters (Fig.4C, S3A,E). To assess in more depth the 242 
similarity of young and old transcriptomes, we calculated the Euclidean distance 243 
distributions of cells within a window of 5 pseudotime units comparing within and 244 
between cells originating from 2 and 22 MO animals. We observed similar distances 245 
within and between the age groups that were much lower than between qNSC1 and 246 
qNSC2 cells (Fig.4D). The same was observed for Euclidean distance distributions of 247 
cells within each separate cluster as compared to cells between qNSC1 and qNSC2 248 
cluster for 10x and Smart-seq2 technologies (Fig.4E, S3F). This comparison and the 249 
DE analysis of age-induced changes within each activation state (Fig. S3F, Table S2), 250 
strongly indicate that age induces lower changes in fewer genes, as compared to 251 
changes induced by lineage transition. In addition, comparison of the average gene 252 
expression of young and old NSCs, or cells within the neurogenic lineage revealed a 253 
much lower number of genes showing expression changes higher than two fold than 254 
for the oligodendrocyte lineage (OD and OPCs) at young and old ages (Fig.S3H).  255 
While the transcriptome associated with a specific pseudotime (i.e., position in the 256 
NSC continuum) does not change with age, the distribution of pseudotime assignment 257 
does. In line with the higher fraction of qNSCS in the old brain (discussed above), we 258 
observed an increase in pseudotime assignments to the early qNSC1 (Fig.4F). While 259 
young NSCs transit smoothly from a quiescent to a primed-quiescent state that is 260 
readily followed by activation, old NSCs remain in the dormant state (qNSC1) and 261 
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fewer cells enter the aNSC0 state, to become fully activated (Fig.4F). Thus the 262 
transcriptional profile of NSCs at different ages remains similar but old NSCs tend to 263 
be in a quiescent state.  264 
Niche inflammatory signals keep old NSCs in a quiescent state 265 
We therefore set out to search for niche-derived signals that could induce quiescence. 266 
To this end, we profiled different cell types residing within the V-SVZ niche 267 
including endothelial cells (ECs), microglia (Mg), NBs and NSCs using bulk RNA 268 
sequencing from 2 and 19MO mice (Fig.S6C). Differential expression analysis 269 
revealed a common enriched expression of transcripts related to inflammatory 270 
response in every cell type (Fig.5A,B, Table S2). It also showed that ECs exhibit the 271 
highest age-related changes (Fig.5A). To explore when is the onset of the 272 
inflammatory response in NSCs we also performed NSC bulk RNA sequencing from 273 
7 MO mice, which revealed that inflammatory genes expression at 7MO is already 274 
higher than in 2MO mice (Fig.5C).  275 
While inflammatory genes expression was captured with bulk RNA sequencing, the 276 
observed age-imposed transcriptional changes were mild to be reliably detected at the 277 
single cell level. Overall, the differences seen in bulk sequencing data are also partly 278 
visible in the single cell SmartSeq2 data for those genes that could be detected in a 279 
sufficiently large fraction of the cells (Fig.S3G). Indeed, analysis of the read counts in 280 
single NSCs sequenced by either 10x 3’ Chromium or Smart-seq2 technology, 281 
revealed that the inflammation signal is too weak and can only be detected by Smart-282 
seq2 (in only few cells) but not by the 10x technology (Fig.S3I, Table S2). Of note, 283 
basal expression of interferon response genes is already observed in young mice, 284 
which is suggestive of a role of interferons in NSC homeostasis. We next assessed the 285 
expression of the nuclear pro-inflammatory cytokine IL33, which has been reported to 286 
activate the innate immune response by inducing interferon production in the NSC 287 
compartment of 2 and 22 MO TLX-CreERT2YFP mice. The proportion of IL33+ 288 
NSCs changed from around 0.5% in the young V-SVZ to 15% in the old V-SVZ 289 
(Fig.5D,E). However, the NSC fraction that is retained in a quiescent state is much 290 
higher. Thus, we hypothesized that inflammatory cytokines derived from neighboring 291 
cells might contribute to induction of quiescence in the NSC compartment. Along this 292 
line, previous studies have shown that sustained inflammation activates Mg to reduce 293 
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proliferation of neighboring NSCs in the young V-SVZ (Solano Fonseca et al., 2016). 294 
In addition, ECs already induce quiescence of NSCs in a non-inflammatory state 295 
(Ottone et al., 2014). Accordingly, exposure of NSCs to inflammatory interferons 296 
(IFNα/β) greatly reduced proliferation of NSCs in vitro (Fig.5F). To address the 297 
contribution of interferons to the age-dependent induction of quiescence, we 298 
examined the fraction of aNSCs among adult-LRCs in 2 and 22 MO IFN receptor-299 
knockout mice (IFNAGRKO) (Fig.S5A). We hypothesized that if inflammation, 300 
specifically interferons, are a main quiescence driver, their absence would result in 301 
NSC dynamics resembling the "no aging" scenario of our MM (Fig.1E). Consistent 302 
with the prediction of our "no aging" model, the fraction of aNSCs among LRCs did 303 
not change across time and was therefore significantly higher in old interferon-304 
deficient animals than in old wild-type counterparts (Fig.5G). Thus, neutralizing 305 
inflammation levels off the age-related decline in activation of V-SVZ NSCs at old 306 
ages. 307 
Finally, we investigated whether an acute inflammation inhibition in the old V-SVZ 308 
niche could activate NSCs in the old brain. Previous reports had shown that the sole 309 
neutralization of the inflammatory cytokine CXCL10 greatly improves hippocampal 310 
synaptic plasticity in the context of an interferon response triggered by a viral 311 
infection (Blank et al., 2016). Therefore, we decided to treat aged animals with a 312 
neutralizing antibody against CXCL10. Mini-osmotic pumps containing anti-313 
CXCL10 or isotype control antibodies were implanted in the lateral ventricles of 22 314 
MO mice and BrdU was administered for 3 days. Olfactory bulb neurogenesis was 315 
assessed by quantification of newborn NBs 4 days later (Fig.S5C). Notably, inhibition 316 
of CXCL10 significantly increased the number of NBs (Fig.5H). To confirm that this 317 
increase was due to activation of qNSCs, we administered BrdU in the drinking water 318 
for 14 days followed by a chase time of 28 days. Mini-osmotic pumps with anti-319 
CXCL10 or isotype control antibodies were implanted 7 days before sacrificing the 320 
animals (Fig.S5A). CXCL10 neutralization significantly decreased the number of 321 
LRCs compared to IgG-treated mice indicating activation of qNSCs (Fig.5I). Thus, 322 
inhibition of CXCL10 decreased the number of qNSCs, and increased the production 323 
of NBs during homeostasis providing a causal link between inflammation and 324 
induction of quiescence in the aged brain.  325 
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A Markov chain approach identifies the Wnt antagonist sFRP5 as an additional 326 
niche signal maintaining quiescence  327 
To identify additional age-related signals contributing to induction of NSC quiescence 328 
emanating from the niche we developed a Markov Chain-based computational 329 
approach  (MCCM; Data S2). This approach aims at unveiling NSC-intrinsic 330 
signaling intermediates that are likely to maintain a specific cell state dictated by 331 
niche signals via a sustained effect on the downstream gene regulatory network 332 
(Ravichandran and Del Sol, 2017) (Fig.6A, Data S2). For this analysis, we used the 333 
Smart-seq2 single cell expression data of qNSCs and aNSCs from young and old 334 
mice. This approach enabled identification of key signaling intermediates likely to be 335 
constantly active or inactive in a majority of cells in the respective cellular 336 
subpopulations, among them Bmpr1a, a regulator of NSC quiescence (Mira et al., 337 
2010) (Table S3). We focused on intermediates identified as uniquely active in old 338 
NSCs. The method identified eight genes uniquely expressed in old qNSC1 (Table 339 
S3).  From these we focused on Sfrp5, a known antagonist of the Wnt signaling 340 
pathway that was strongly expressed in old qNSCs (Fig.S4A,B; TableS3). To address 341 
potential age-dependent changes in canonical Wnt-activity, we used TCF/Lef-H2B-342 
GFP reporter mice that express an H2B-GFP fusion protein under the control of 6 343 
TCF/Lef binding sites (Ferrer-Vaquer et al., 2010). We observed a higher fraction of 344 
GFP+NSCs among NSCs in the dorsal domain as compared to the latero-ventral 345 
domain of V-SVZ (Fig.6B-D), in line with the previously described function of Wnt-346 
canonical signaling in generation of oligodendrocyte lineage within the dorsal domain 347 
(Ortega et al., 2013). Ependymal cells, which lie along the entire wall of the lateral 348 
ventricles, were GFP positive (Fig.6C). Importantly, the total number of GFP+NSCs 349 
significantly increased (1.4 fold) at 8MO as compared to 2MO (Fig.6D). Most DCX- 350 
Ki67+ cells which can only be active NSCs or TAPs were TCF-LEF negative 351 
indicating that canonical Wnt activity is high in qNSCs (Fig.S4C,D). Then, we 352 
hypothesized that sFRP5 antagonizes non-canonical Wnt activity thereby leading to 353 
increased canonical-activity and thus quiescence in the aging brain. Thus, we tested if 354 
neutralization of sFRP5 could decrease quiescence in old NSCs by administering a 355 
neutralizing antibody against human sFRP5 in vivo. We confirmed that this antibody 356 
was able to recognize mouse recombinant sFRP5 in vitro, and able to block Wnt3a-357 
mediated activity in a TOPFLASH assay (Fig.S4E). Thereafter, we used the LRC 358 
protocol followed by a chase time of 6 weeks and implanted mini-osmotic pumps 359 
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containing anti-sFRP5 or isotype control antibodies 7 days before sacrificing the 360 
animals (Fig.S5A). We observed a significantly decreased number of LRCs following 361 
sFRP5 inhibition as compared to IgG-treated control old mice (Fig.6E). We thereafter 362 
tested the effect of sFRP5 inhibition in NSC-mediated repair of the injured niche. To 363 
this end we challenged the animals with TMZ and implanted mini-osmotic pumps 6 364 
days before sacrificing them (Fig.S5B). sFRP5 inhibition significantly increased the 365 
number of proliferating cells, as assessed by a 2h-BrdU labeling protocol, in old mice 366 
as compared to IgG-treated control old mice (Fig.6F). Thus, neutralization of sFRP5 367 
can release the brake on NSC activation in the old brain during homeostasis but also 368 
following injury. 369 
Discussion 370 
A role of quiescence in preserving a reservoir of stem cells in the aged brain 371 
Although previous studies had already reported a shrinkage of the V-SVZ NSC pool 372 
with age (Ahlenius et al., 2009; Obernier et al., 2018; Shook et al., 2012; Silva-373 
Vargas et al., 2016), others have reported no age-related changes (Daynac et al., 374 
2016). This study confirms that the pool of adult V-SVZ-NSCs exhibits an age-375 
dependent depletion, using three independent methods: counting marker positive cells 376 
by FACS, and immunostainings of embryonically- and adult-LRCs of the young and 377 
old V-SVZ. As previously hypothesized (Obernier et al., 2018) and as confirmed by 378 
the “no-aging” scenario of our mathematical modeling, the fact that NSCs have a 379 
higher probability to differentiate than to undergo self-renewing divisions leads to a 380 
time-dependent attrition. Indeed, without an age-dependent increase in the fraction of 381 
qNSCs, NSCs would undergo full depletion in the old brain. This prediction does not 382 
exclude an additional contribution of changes in other parameters but reveals that 383 
changes in “time-in-quiescence” is the only parameter which regulation allows 384 
reproducing the data on its own. Furthermore, allowing time dependent changes in 385 
quiescence and self-renewal, revealed that even if the two parameters undergo age-386 
dependent changes, it is the time-increasing quiescence (decreasing rate of activation 387 
from quiescence), which is the major component of the regulatory process and allows 388 
explaining the observed dynamics. Notably, models accounting for other transitions, 389 
such as asymmetric divisions of the form aNSC→progenitor+qNSC, or assuming co-390 
existence of both types of divisions, additional cell death or direct fate transitions into 391 
astrocytes (Ziebell et al., 2018), yield the same conclusion, which indicates the 392 
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universality of aging-induced quiescence. Accordingly, a lower fraction of LRCs that 393 
become reactivated in the aging brain has been independently detected through 394 
ultrastructural analysis of V-SVZ NSC following incorporation of radioactive 395 
thymidine (Capilla-Gonzalez et al., 2014). 396 
Contrary to the present study, others have reported an age-dependent increase of cell 397 
cycle length (Daynac et al., 2016). Daynac et al., detected a higher fraction of cells 398 
claimed to be in G1 state in the aging brain using FUCCI-reporter mice.  399 
Unfortunately, this reporter line cannot distinguish between G1 or G0 and thus, the 400 
data could be interpreted as increased cell cycle length (of G1) as done by the authors 401 
or as an increased number of cells in a quiescent state (G0). In summary, our study 402 
reveals that upon aging a higher fraction of NSCs is found in quiescence and this is a 403 
compensatory mechanism to avoid full depletion of the NSC compartment.  404 
In addition, and as opposed to the concept of malfunctioning aged stem cells, our 405 
study reveals that once activated old NSCs perform as well as younger counterparts in 406 
undergoing several rounds of division and generating clones with similar numbers of 407 
neurons. This is also demonstrated by similar levels of DNA damage in young and old 408 
NSCs, in contrary to the higher levels reported in HSCs following chronic 409 
inflammation (Walter et al., 2015). Likewise, analysis of single cell and bulk 410 
transcriptomes of old and young NSCs reveals that the large scale transcriptional 411 
activity of the cells is given by their metabolic state and that age induces milder 412 
transcriptional changes that suffice to block transition from a quiescence to an active 413 
state. This study suggests that age globally changes the neurogenic niche, which 414 
impairs NSC activation. Once NSCs become activated they function as well as young 415 
NSCs. 416 
Inflammatory signals from the niche impose quiescence 417 
The fraction of qNSCs in the old brain is not only increased, but is also more resistant 418 
to exiting quiescence even if forced by injury. Resistance to become activated has 419 
been shown only in vitro so far and it was linked to defects in lysosomal clearance in 420 
old NSCs (Leeman et al., 2018). We, however, found a link of quiescence to 421 
inflammation. Inhibition of the interferon response through deletion of interferon 422 
receptor  and  led to a similar fraction of aNSCs in young and old V-SVZ. 423 
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Importantly, these kinetics of the fraction of aNSCs in young and old interferon 424 
receptor deficient mice was predicted by the “no-aging” scenario.  425 
We have previously found that activation of interferon-response is required to 426 
increase activation of young NSCs upon injury (Llorens-Bobadilla et al., 2015). The 427 
opposing function of interferon in injured young NSCs might be due to the duration 428 
of exposure to interferon, acute for injury vs. chronic exposure in aging, or to the 429 
prevalence of interferon- activity in aging vs. interferon- in injury. Interferons 430 
derived from the choroid plexus had been reported to negatively impact adult 431 
hippocampal neurogenesis in the old brain (Baruch et al., 2014). However, how 432 
interferons decrease de-novo generation of neurons was not addressed. 433 
Our study underlines the importance of the niche for induction of quiescence. An age-434 
dependent expression of transcripts related to inflammatory response is globally 435 
detected in the old niche, suggestive of a major contribution of the niche in induction 436 
of NSCs quiescence. Accordingly, models of heterochronic parabiosis have identified 437 
an age-related increase of systemic inflammatory factors, such as the cytokine 438 
CCL11, which are detrimental for hippocampal neurogenesis and cognitive functions 439 
(Villeda et al., 2011). Similarly, GDF11 was identified as a systemic factor that 440 
“rejuvenates” the aged V-SVZ (Katsimpardi et al., 2014). It would be interesting to 441 
address if the rejuvenating effect by this systemic factors is solely due to inhibition of 442 
quiescence. Interestingly, increased interferon response was also detected in human 443 
aging brains (Baruch et al., 2014). In summary, our study establishes a causal link 444 
between inflammation and quiescence, and shows that an early gain of quiescence 445 
would decrease the fraction of aNSCs at young age that then would be maintained at 446 
old ages. In addition, an acute inhibition of inflammation at old age can help 447 
increasing de novo neuronal production in the old brain. Along this line, the 448 
difficulties in finding newborn neurons in the adult human brain (Kempermann et al., 449 
2018) might be explained by the increased quiescence of adult human stem cells.   450 
Control of Wnt activity by the niche through sFRP5 451 
Finally, application of a Markov chain-based computational approach that aimed at 452 
discovering niche signals maintaining old NSCs in quiescent state, identified the Wnt 453 
antagonist sFRP5. Modulation of two other Wnt antagonists, DKK1 and sFRP3, had 454 
been reported to control expansion of hippocampal NSCs in the young and old brain 455 
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(Jang et al., 2013; Seib et al., 2013). Notably, our mathematical modeling of NSC 456 
dynamics in the hippocampus predicted that neutralization of DKK1 increases the 457 
generation of neurons in the aging brain by increasing the time in quiescence (Ziebell 458 
et al., 2018). Importantly, DKK1 antagonizes canonical Wnt signaling, as opposed to 459 
sFRP5 that putatively antagonizes non-canonical Wnt signaling, which suggest that in 460 
both neurogenic niches the switch from canonical to non-canonical is required to 461 
enter the activation state. Zhu et al. detected decreased canonical Wnt activity in the 462 
old V-SVZ as compared to younger counterparts (Zhu et al., 2014). This study used 463 
an Axin2-Gal reporter as read out for canonical Wnt signal and did not specifically 464 
address its expression in NSCs but in the whole V-SVZ tissue, which as we show now 465 
is masked by the highest expression in the ependymal compartment. Using a TCF/Lef 466 
reporter, we found that canonical Wnt activity was majorly found in Ki67 negative 467 
cells, and thus, qNSCs. We hypothesize that a switch to non-canonical Wnt activity is 468 
required to enter activation at all ages, but in the aging V-SVZ this activity can be 469 
inhibited by sFRP5. Accordingly, we show that an acute block of sFRP5 increased the 470 
fraction of actively cycling NSCs in the old brain following homeostasis and a 471 
temozolomide-injury. Likewise, inhibition of canonical Wnt activity in the old bone 472 
improved bone healing (Baht et al., 2015). In the hematopoietic system, however, a 473 
detrimental increase of non-canonical Wnt signaling was found in aged HSCs (Florian 474 
et al., 2013). In summary, Wnt activity, either canonical or non-canonical, crucially 475 
regulates activation of adult somatic stem cells. Importantly, a link between Wnt 476 
activity and inflammation has been speculated in the old and the injured brain 477 
(Marchetti and Pluchino, 2013). A good example are Mg that use non-canonical or 478 
canonical Wnt activity to respectively activate or inhibit expression of inflammatory 479 
cytokines (Marchetti and Pluchino, 2013). Also, inflamed Mg decrease NSC 480 
proliferation and neuronal production (Solano Fonseca et al., 2016). Thus, we 481 
speculate that an attempt to block inflammation in niche cells such as Mg, through 482 
increased expression of antagonist of the non-canonical Wnt signaling results in a 483 
brake on activation of NSCs. This would explain why blocking inflammation or 484 
expression of sFRP5 would similarly lead to increased exit of quiescence in old 485 
NSCs. 486 
In summary, this study reveals that quiescence induction is used to preserve a small 487 
pool of NSCs in the old brain.  Aged NSCs perform as well as their younger 488 
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counterparts once activated but are more resistant to becoming activated. Analysis of 489 
the bulk or individual transcriptomes of NSCs shows that transitions throughout the 490 
different activation states are underlined by profound transcriptional changes in 491 
metabolism-related programs that can be readily detected at the single cell level. 492 
However, age-related transcriptional changes are too mild to be reliably detected at 493 
the single cell level and could only be detected by bulk-sequencing or predicted by 494 
the Markov chain approach. In addition, this study reveals a causal link between 495 
maintenance of quiescence, inflammation and non-canonical Wnt-activity. 496 
Understanding how to modulate the balance between quiescence and activation of 497 
NSCs in the old brain will be critical to preserve stem cell function in the aging brain.  498 
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Figure Legends 720 
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Figure 1, A time-dependent increase in quiescence maintains a stem cell 721 
reservoir at old age. A) FACS analysis of total number of NSCs, qNSCs, aNSCs and 722 
TAPs from both V-SVZs of mice of different ages (2 MO, n=6 replicates of 2 pooled 723 
mice; 7 MO, n=3 replicates of 2 pooled mice; 22 MO, n=3 pools of 3 mice; bar and 724 
whiskers denote mean ± SD; Tukey-Kramer multiple-comparisons test). B) 725 
Representative pictures of 2 MO and 14 MO SVZ (scale bar: 20 μm; white arrows 726 
indicate E-LRCs). C) Quantification of total number of YFP+Sox2+BrdU+DCX-727 
S100b- cells/SVZ/Section at 2 and 14 MO (n=3 mice/group; bar and whiskers denote 728 
mean ± SD; Student’s t-test). D) Schematic representation of MM. qNSCs can enter 729 
the cell cycle to become aNSCs. aNSCs divide to either produce two qNSCs or two 730 
TAPs (progn). Progenitors have the capacity of n symmetric self-renewing divisions, 731 
which give rise to neuroblasts (nblast). Fit of neurogenesis model to the data 732 
assuming no aging (E); cell cycle lengthening (F); increasing self-renewal (G); or 733 
increasing quiescence (H) (red represents model and black experimental data). I) 734 
Quantification of fraction of Ki67+ among YFP+Sox2+BrdU+S100b- cells at 2, 7 and 735 
14 MO (n=3 mice/group; bar and whiskers denote mean ± SD; Tukey-Kramer 736 
multiple-comparisons test). *p <0.05; ** p <0.01; *** p <0.001; n.s.: not significant. 737 
Figure 2, qNSCs are resistant to activation while aNSCs exhibit similar behavior 738 
in the young and old brain. A) Schematic representation of experimental setup.  B) 739 
Quantification of BrdU+ cells/SVZ/Section in 2 MO and 22 MO mice (Each data 740 
point represents a mouse; bar and whiskers denote mean ± SD; Tukey-Kramer 741 
multiple-comparisons test; statistics compared to the control group –saline-). C) Phase 742 
contrast time-lapse microscopy pictures of sorted 2 MO and 22 MO aNSCs for 5 743 
days. (day:hour:minute). Post-imaging immunocytochemistry for GFAP (white), NG2 744 
(red) and βIII-tubulin (green) and lineage tree for the depicted clones (scale bar: 20 745 
μm). D) Average clone size of dividing cells. E) Average number of division rounds 746 
per clone. F) Average cell cycle length per clone (2 MO n=39 clones, 22 MO n=21 747 
clones; bar and whiskers denote mean ±SEM). *** p <0.001; n.s.: not significant. 748 
Figure 3, The individual transcriptomes of young and old NSCs (Smart-seq2 749 
technology) show an increased fraction of old qNSCs A) PCA plot for the 750 
transcriptomes of 92 NSCs of 2 MO mice (circles) from Llorens-Bobadilla et al., 751 
2015 and 133 NSCs of 23 MO mice (triangles). Colors indicate different activation 752 
states, as identified from the hierarchical clustering in Llorens-Bobadilla et al., 2015. 753 
See Table S1. B) PCA plots of individual subpopulations of NSCs sequenced with the 754 
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Smart-seq2 protocol. Green dots represent cells from 2 MO and purple triangles cells 755 
from 23 MO mice. C) Pie charts representing the fraction of NSCs in different 756 
activation states from 2 and 23 MO mice. D) Heatmap of manually selected genes 757 
involved in DNA damage response pathways. E) Log2-transformed TPM gene 758 
expression values of all the DE genes (with absolute log fold change >1 and p<0.01) 759 
between old qNSC1 and astrocytes, shown for qNSC1, qNSC2 cells and astrocytes 760 
from the Smart-seq2 data. Upper half: upregulated genes that are expressed higher in 761 
qNSC1s than in astrocytes. Lower half: downregulated genes that are expressed lower 762 
in qNSC1s than in astrocytes. See Table S2. F) Box plots of CD9 expression in 763 
astrocytes and qNSC1 cells from 2 and 23 MO mice (Likelihood ratio test, adjusted 764 
pval <0.003). 765 
Figure 4, Single cell transcriptomics (Chromium Cell 3’ platform) uncovers a 766 
remarkable similarity between young and old NSCs. A) t-distributed stochastic 767 
neighborhood-embedding (t-SNE) of 1696 cells from 2MO and 1370 cells from 22 768 
MO mice. Colors indicate assigned activation states and cell types.  B) Ordering of 769 
young and old single cell transcriptomes using monocle 2. The pseudotime order 770 
agrees with the assigned activation states. C) Same t-SNE map as in panel A, with 771 
colours representing cells from 2 (green) and 22 MO (purple) mice. The good 772 
intermixing indicates absence of noticeable batch effects. D) Euclidean distance 773 
distributions of cells within a window of 5 pseudotime units comparing within and 774 
between cells originating from 2 and 22 MO animals. Euclidean distance between 775 
cells from qNSC1 and qNSC2 activation states within a pseudotime window of 5 776 
units serves as reference. Lines denote the mean Euclidean distance observed. E) 777 
Comparison of Euclidean distance distributions between cells of the same activation 778 
state from young and old, young and young, old and old mice (overlayed). Euclidean 779 
distance between qNSC1 and qNSC2 serves as reference.  F) Density estimate of cell 780 
number along the pseudotime from qNSC1 to aNSC2 per age group. 781 
Figure 5, Niche inflammatory signals keep old NSCs in a quiescent state. A) 782 
Mean log2 fold change per gene in the comparison between 19 and 2MO bulk 783 
samples (NSCs, ECs, Mg and NB cells). Red dots represent significantly DE genes 784 
(padj<0.05, absolute log2 fold change >1). Blue dots represent significantly 785 
upregulated genes annotated as innate immune response genes by InnateDB (Breuer 786 
et al., 2013). B) Gene ontology analysis of genes upregulated upon aging (>2 fold 787 
change, pvalue<0.05) of bulk populations from different SVZ cell types. See Table 788 
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S2. C) Mean log2 fold change per gene in the comparison between 7 vs 2 MO bulk 789 
sequencing samples of NSCs. Red dots represent significantly DE genes (padj<0.05, 790 
absolute log2 fold change >1). Blue dots represent significantly upregulated genes 791 
annotated as innate immune response genes by InnateDB (Breuer et al., 2013) from 792 
the comparison of 19 vs 2 MO. D) Representative picture of old SVZ 793 
immunostainings for IL33, YFP and DCX (scale bar: 10 μm; white arrows indicate 794 
Il33- and yellow Il33+ NSCs). E) Fraction of IL33+ among YFP+SOX2+DCX- cells 795 
at 2 and 22 MO mice (n=3 mice/group; bar and whiskers denote mean ± SD; 796 
Student’s t test). F) % of Ki67+ among Sox2+ NSCs after 48 hours of treatment with 797 
IFN; (n=4 primary cell lines; bar and whiskers denote mean ± SD; Student’s t 798 
test). G) % of Ki67+ among Sox2+LRC+DCX- NSCs in 2 MO and 22 MO WT and 799 
IFNAGR KO mice (n=3 mice/group; bar and whiskers denote mean ± SD; Tukey-800 
Kramer multiple-comparisons test). H) Number of DCX+BrdU+ cells arriving in the 801 
OB after CXCL10 inhibition normalized to the area (IgG n=8 mice, anti-CXCL10 802 
n=7 mice; bar and whiskers denote mean ± SD; Student’s t test). I) Number of LRCs 803 
(BrdU+DCX-S100b-)/SVZ/Section after CXCL10 inhibition (n=3 mice/group; bar 804 
and whiskers denote mean ± SD; Student’s t test). * p<0.05; ** p <0.01; **** p 805 
<0.0001; n.s.: not significant. 806 
Figure 6, A Markov chain approach identifies the Wnt antagonist sFRP5 as 807 
additional niche signals maintaining quiescence. A) MCCM of a toy-signaling 808 
network in two different niches. The node colors in the network represent the 809 
probability of the signal to be in a specific node (molecule). The edge thickness 810 
represents the interaction probability of the two molecules inferred from single-cell 811 
RNA-seq. At t=0, all nodes have equal probability to contain the signal, and with 812 
increasing time the probability of signal to be present in a molecule changes and 813 
eventually, the system reaches a steady state probability distribution, based on which 814 
the niche specific signaling molecules (in purple) are identified. See Table S3.  B, C) 815 
Representative pictures of the dorsal (B) or lateroventral (C) SVZ from 2 MO and 8 816 
MO mice (White arrows indicate TCF/Lef+ and yellow TCF/Lef- NSCs) (scale bars; 817 
left panel: 20 μm, right panel: 10 μm). D) Quantification of TCF/Lef+ among 818 
GFAP+SOX2+DCX-S100b- NSCs in whole, dorsal and lateroventral SVZ (2 MO 819 
n=2, 8MO n=3; bar and whiskers denote mean ± SD; Student’s t test). E) Number of 820 
LRCs (BrdU+DCX-) after IgG or anti-sFRP5 (n=4 mice/group; bar and whiskers 821 
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denote mean ± SD; Student’s t test). F) Number of BrdU+ cells in the SVZ after 822 
TMZ-injury and treatment with IgG or anti-sFRP5 (n=10 mice/group; bar and 823 
whiskers denote mean ± SD; Student’s t test). *p<0.05. 824 
 825 
Supplemental Figure Legends 826 
Figure S1, Quiescence of NSCs increases upon aging, Related to Fig.1. A) 827 
Representative picture of cells from the V-SVZ 2MO TLX-CreERT2YFP (scale bar: 828 
20 m). B) Fraction of BrdU+ cells among YFP+DCX- cells in 2, 7 and 22 MO (Each 829 
data point represents one mouse; bar and whiskers denote mean ± SD; Tukey-Kramer 830 
multiple-comparisons test). C) Representative picture of a Ki67+LRC+ cell in the 831 
SVZ of 22 MO. (Scale bar:10 m) D) Fraction of Ki67+ cells among LRC+DCX- in 832 
2, 7 and 22MO (n=3 mice/group; bar and whiskers denote mean ± SD; Tukey-Kramer 833 
multiple-comparisons test). E) Fit of the neurogenesis model with increase of self-834 
renewal during aging. The cell counts at age 0 are in the order of 10^6. F) Upper 835 
panel: Fit of the neurogenesis model with simultaneous increase of quiescence and 836 
self-renewal during aging. Lower panels: Model with simultaneous increase of 837 
quiescence and self-renewal during aging: Time course of self-renewal fraction and 838 
activation rate. The activation rate from quiescence significantly decreases in time. 839 
The self-renewal fraction only slightly changes at younger ages. The red curves 840 
correspond to model simulations. Each black dot denotes experimental data of one 841 
mouse. G) Representative pictures of embryonically BrdU-labelled YFP+ cells that 842 
are Ki67+ (yellow arrow) or Ki67- (white arrow) (scale bar: 10 m). *p<0.05; ** p 843 
<0.01; *** p <0.001; n.s.: not significant. 844 
 845 
Figure S2, DNA damage does not increase upon aging and old aNSCs have 846 
similar properties to young, Related to Fig.2. A) Maximum intensity projection 847 
micrographs (scale bar: 10 μm) of dorsal SVZ from 2 and 22 MO mice at different 848 
time points after TMZ injection. (note the increase in autofluorescent lipofuscin 849 
speckles all over the 22 MO brains). B) Representative pictures of intact or damaged 850 
nuclei after 5Gy gamma irradiation. C) Quantification of the olive tail moment (active 851 
old n=257 cells, active young n=274 cells, quiescent old n=150 cells, quiescent young 852 
n=245 cells). D) Lineage trees of 2 MO and 22 MO aNSCs. E) Representative 853 
pictures of spheres derived from single aNSCs from 2, 7 and 22 MO mice (scale bar: 854 
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200 μm). F) Quantification of sphere diameter (2 MO and 22 MO n=4, 7MO n=2; bar 855 
and whiskers denote mean ± SD; Tukey-Kramer multiple-comparisons test).  n.s.: not 856 
significant. 857 
 858 
Figure S3, Transcriptomic analysis, Related to Fig. 3 and 4. A) tSNE map of cells 859 
from the neurogenic lineage colored by pseudotime as assigned by monocle2 (10x 3’ 860 
Chromium). B) Distributions of euclidean distances between cells from different 861 
activation states. Although there is a gap between the qNSC1 and qNSC2 in the t-862 
SNE plot the comparison of the distance distibutions shows that the distance between 863 
qNSC1 and qNSC2 is similar to the distance of qNSC2 and aNSC0, which are not 864 
separated by a gap. The distance distribution of qNSC1 compared to OD as expected 865 
shows a higher distance between these cell types, while the aNSC clusters are closer 866 
together (10x 3’ Chromium). C) Heatmap of differentially expressed genes for the 867 
identified cell clusters (gene-wise z-scores). Columns (cells) are sorted by their 868 
monocle assigned pseudotime from left to right (for cells from the neurogenic 869 
lineage), while cells from OPC and OD are added to the right without further sorting. 870 
Rows (genes) were ordered by increasing onset of expression along the pseudotime 871 
from top to bottom. Differentially expressed genes for OPC and OD were added to the 872 
bottom. See Table S1 (10x 3’ Chromium). D) Heatmap displaying expression of 873 
selected genes (gene-wise z-scores) from recently published sc RNAseq data of young 874 
SVZ (Basak et al., 2018) in cells of our study sequenced with the 10x genomics 875 
platform (10x 3’ Chromium). E) PCA plots of individual subpopulations of NSCs 876 
sequenced (10x 3’ Chromium). F) Comparison of euclidean distance distributions 877 
between cells of the same activation state from young and old, young and young, old 878 
and old mice. Euclidean distance between qNSC1 and qNSC2 serves as reference. 879 
(Smart-seq2). The right panel shows a detailed view of changes in mean expression 880 
and SD for each gene between old and young within qNSC1 (upper) and in the 881 
transition qNSC1qNSC2 in young and old (lower). G) Scatter plot of genes in the 882 
Smart-seq2 data that were differentially expressed upon aging in bulk NSCs. Y-axis 883 
indicates the difference of the average log-transformed TPM values between old and 884 
young. X-axis denotes the fraction of cells without any reads for this gene in either 885 
old or young. To this end we calculated the fraction separately for young and old and 886 
used the larger value. Color denotes the direction of change in the bulk sequencing 887 
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data. H) Scatter plots comparing gene expression between 22 and 2 MO mice, 888 
averaged over all NSCs, the neurogenic lineage, ODs or OPCs. Dotted lines represent 889 
2 fold-change (genes >2 FC are shown in black) (10x 3’ Chromium). I) Barplots 890 
representing the percentage of cells with read counts stratified in 4 different intervals 891 
(0, 1-5, 5-50, >50) of top genes related to immune response upregulated in Bulk 892 
sequencing between old and young NSCs in (10x 3’ Chromium and Smart-seq2). 893 
Figure S4, Related to Fig. 6. A) Expression of Sfrp5 from Smart-seq2 single cell 894 
data (bar and whiskers denote mean ± SD). B) Expression of Sfrp5 in bulk 895 
populations of NSCs at 2, 7 and 19 MO NSCs (dots represent biological replicates). 896 
C) Representative pictures of TCF/Lef expression among Ki67+ cells (scale bars: 20 897 
μm) in 2 and 8 MO mice (arrows indicate examples of Ki67+ cells that are TCF/Lef-. 898 
D) Quantification of TCF/LEF+ among Ki67+ cells (2 MO n=2, 8MO n=3; data 899 
shown as mean ±SD). E) TOPFLASH assay with HEK 293 cells (Data shown as 900 
mean ±SD). 901 
 902 
Figure S5,  Related to Fig. 1, 2, 5, 6, S1. Experimental outlines of experiments 903 
across the article.  A) Approaches to label and follow e-LRC or LRC NSCs. B) 904 
Labelling of proliferating cells in the SVZ with a 2 hr pulse of BrdU. C) Labelling of 905 
newly-born NBs arriving at the olfactory bulb.  906 
 907 
Figure S6, Related to Fig. 1, 2, 3, 4, 5, S2. FACS strategies followed for the 908 
isolation and analysis of V-SVZ cell populations. A) Strategy for the isolation of 909 
qNSCs, aNSCs and TAPs. B) Strategy for preparation of libraries for 10x Chromium 910 
3’. C) Strategy followed to isolate different populations of cells from the V-SVZ 911 
niche.  912 
STAR Methods 913 
Author information 914 
RNAseq raw sequence data is available from GEO (Accession number: GSE115626). 915 
All the analysis is described in the methods section. The complete R/Bioconductor 916 
software package will available upon acceptance on the authors’ webpage 917 
(https://martin-villalba-lab.github.io/). Correspondence and requests for materials 918 
should be addressed to AMV (a.martin-villalba@dkfz-heidelberg.de). 919 
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Mouse strains  920 
Male C57BL/6 mice were purchased from Janvier or bred in house at the DKFZ 921 
Center for Preclinical Research facility. Male IFNRKO (Huang et al., 1993; Muller et 922 
al., 1994) (IFNAR-/-IFNGR-/-) 2 and 22 MO were backcrossed to a C57BL6 923 
background. Male and female Tlx-CreERT2YFP (Liu et al., 2010) were used 924 
according to the protocols in Figure S5. Male 2 MO and 8 MO TCF/Lef:H2B/GFP 925 
were used to assess TCF/Lef activity (Ferrer-Vaquer et al., 2010). Animals had ad 926 
libitum access to food and water and were kept under a 12hr light-12hr dark cycle. All 927 
procedures were approved by the Regierungpräsidium Karlsruhe.  928 
Implantation of mini-osmotic pumps 929 
Mice were anaesthetized with isofluorane and a mini-osmotic pump (Alzet Model 930 
1007D, Brain infusion Kit 3) with a volume of 100 μl and a flow rate of 0.5 μl/h 931 
containing different antibodies was implanted 1.1 mm lateral and 0.5 mm posterior to 932 
the bregma according to the manufacturer’s instructions.  933 
BrdU 934 
BrdU (Sigma) was dissolved in 0.9% saline solution at 10 mg/ml and was heated at 935 
50oC until it was completely dissolved. For intraperitoneal injections (I.P) appropriate 936 
amount of BrdU was administered to match the concentrations indicated at Figure S5. 937 
For BrdU administration in drinking water, BrdU was dissolved in water with 0.1% 938 
sucrose in a concentration of 1 mg/ml. For embryonic labeling timed-pregnant TLX-939 
CreERT2YFP mothers were injected with two shots of BrdU (50 mg/kg) six hours 940 
apart at embryonic day 14 (E14).  941 
Temozolomide (TMZ) treatment 942 
Temozolomide dissolved in 75% saline 25%DMSO (or 0.9% saline in control 943 
animals) was injected daily I.P. in a concentration of 100mg/kg. BrdU was 944 
administered I.P. at 100mg/kg and mice were sacrificed 2 hours after injection or as 945 
indicated in the protocol. 946 
Tamoxifen 947 
TLX-CreERT2YFP pups embryonically labeled with BrdU, were given two shots of 948 
Tamoxifen (Sigma-Aldrich, 83.35 mg/kg, 9 Sunflower seed oil:1 100% EtOH) 12 hrs 949 
apart from postnatal day 28 till 32. 950 
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TLX-CreERT2YFP mice 2, 7 and 22 MO were given two shots of Tamoxifen 951 
(50mg/kg) 12 hrs apart for 5 days. 952 
Treatments with neutralizing antibodies 953 
Mini-osmotic pumps were filled with 100 l of neutralizing antibodies or isotype 954 
controls at the following concentrations: for sFRP5 neutralization 333 g/ml of 955 
Mouse IgG2B Isotype control (Novus, MAB0041) or anti-sFRP5 (Novus, MAB6266) 956 
dissolved in PBS were used. For CXCL10 neutralization 500 g/ml Purified 957 
Armenian Hamster IgG Isotype control (Biolegend, 400902) or Armenian Hamster 958 
anti-CXCL10 from Urs Christen were used. 959 
FACS analysis and sorting 960 
Generation of single cell suspension and stainings for FACS analysis or FACS sorting 961 
were performed as described in (Llorens-Bobadilla et al., 2015). Briefly, mice were 962 
sacrificed, SVZ was microdissected and single cell suspension was obtained using the 963 
Neural Tissue Dissociation kit with Trypsin (or Papain when staining for CD31+ and 964 
CD11b+ cells) and Gentle MACS dissociator (Miltenyi). For staining the following 965 
antibodies were used: Ter119 APC-Cy7 (Biolegend, 1:100), O4 APC and APC-Cy7 966 
(Miltenyi, 1:50), CD45 APC-Cy7 (BD, 1:200), GLAST (ACSA-1)-PE and APC 967 
(Miltenyi, 1:20), Prominin1-APC and PerCP-eFluor 710 (eBioscience, 1:75), 968 
Alexa488::EGF (Life Technologies, 1:100), PSA-NCAM PE-Cy7 Miltenyi, 1:75), 969 
CD31-PE (BD, 1:100), CD11b-APC (BD, 1:100) and Sytox Blue (Life Technologies, 970 
1:1000).  971 
Time-lapse video microscopy 972 
Sorted quiescent and active NSCs from 2 and 22 MO mice were plated and tracked. 973 
Ex vivo activation of quiescent NSCs was rare. Hence our analysis was restricted to 974 
aNSCs. Video microscopy of primary adult neural stem cell cultures was performed 975 
with a Cell Observer (Zeiss) at constant conditions of 37 °C and 8% CO2 as 976 
previously described (Ortega et al., 2013). Phase contrast images were acquired every 977 
5 minutes for 5-6 days using a 20 X phase contrast objective (Zeiss) and an 978 
AxioCamHRm camera with a self-written VBA module remote controlling Zeiss 979 
AxioVision 4.7 software (Rieger et al., 2009). Time-lapse videos were assembled by 980 
using ImageJ whereas single-cell tracking was carried out using a self-written 981 




Mice were transcardially perfused with ice cold HBSS and 4% PFA. Brains were 984 
post-fixed in 4% PFA O/N and subsequently immersed in 30% sucrose. 15 μm 985 
sections were prepared using a cryotome. For stainings of E-LRCs, 50 μm sections 986 
were prepared at the vibratome. Sections were blocked for unspecific labeling in 987 
0.25% Triton X-100, 3% horse serum for 1 hr at RT and consequently with primary 988 
antibody mix at 4oC O/N. Sections were washed and incubated with secondary 989 
antibodies in blocking buffer for 90’ at RT. Primary antibodies used were: anti-DCX 990 
(guinea-pig, Merck Millipore, 1:1000), anti-GFP (chicken, Aves, 1:1000), anti-Sox2 991 
(goat, Santa Cruz, 1:500), anti-BrdU (rat, abcam, 1:100), anti-S100b (rabbit, abcam, 992 
1:100), anti-GFAP (rat, thermo fischer, 1:1000),  anti-Ki67 (rabbit, novus, 1:200), 993 
anti-IL33 (goat, novus, 1:150). 4-8 sections, 6 sections apart were used for 994 
immunostainings.  995 
Cells 996 
Labtek chambers were coated with PDL/laminin and NSCs were seeded at a density 997 
20000/cm2 and treatments followed. Cells were blocked for unspecific staining in 998 
0.25% Triton X100, 3% horse serum for 30’ at RT and consequently with primary 999 
antibody mixture containing anti-beta III-tubulin (mouse IgG2b, Sigma, 1:300), anti-1000 
GFAP (mouse IgG1, Sigma, 1:800), anti-NG2 (rabbit, Millipore, 1:500) at 4oC O/N.  1001 
Isolation and cultivation of NSCs in vitro 1002 
SVZ was microdissected and single cell suspension was prepared using the Neural 1003 
Tissue Dissociation kit with Papain (Miltenyi). Cells were transferred in Neurobasal 1004 
A (NBM A) medium containing 2% B27 supplement serum (Gibco), 1% L-1005 
Glutamine, 2 g/ml of Heparin, 20 ng/l of human FGF basic growth factor 1006 
(ReliaTech), 20 ng/l of human EGF (Promokine). Cells were not used for longer 1007 
than 10 passages.  For treatment with recombinant mouse interferons /, 160 U/ml 1008 
(Millipore) were added in NSC medium and cells were incubated for 48 h. 1009 
Luciferase Reporter (Topflash) assays 1010 
Luciferase reporter assays were performed as previously described (Berger et al., 1011 
2017). 1012 
Briefly, HEK293T cells were grown in 96‐well plates and transfected with 5 ng 1013 
Topflash, 1 ng Renilla and 44 ng empty vector (pCS2+) DNA using X‐tremeGene 9 1014 
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transfection reagent (Roche) and following the supplier's protocol. 24 h after 1015 
transfection, cells were stimulated with the indicated conditions: CHAPS control or 1016 
recombinant Wnt3a protein (Peprotec, 180 ng/mL) with or without recombinant 1017 
sFRP5 protein (Novus, 5 µg/mL). To examine if neutralizing sFRP5 antibody can 1018 
inhibit recombinant sFRP5, recombinant Wnt3a together with sFRP5 and the 1019 
neutralizing antibody (Novus, 5 or 25 µg/mL) were pre-incubated at room 1020 
temperature for 30 minutes before applied to the cells. After 24 h, cells were 1021 
harvested and Luciferase activity was determined following the manufacturer’s 1022 
manual (Promega, Dual-Luciferase Reporter Assay System). Values are presented as 1023 
Firefly activity normalized to Renilla values. 1024 
Sphere assay 1025 
aNSCs (CD45-O4-Ter119-GLAST+CD133+EGFR+) (Figure S6A) from 2, 7 and 22 1026 
MO were sorted in 96 wells containing 3x growth factors and the diameter of spheres 1027 
was measured 5 days later using a LEICA table microscope.    1028 
Comet assay 1029 
qNSCs (CD45-O4-Ter119-GLAST+CD133+EGFR-) and aNSCs (CD45-O4-Ter119-1030 
GLAST+CD133+EGFR+) (Figure S6A) were isolated in NBM A with B27 and 1031 
comet assay was performed as described in (Walter et al., 2015) with the difference 1032 
that low-melting-temperature agarose was purchased from Biozym.  1033 
Microscopy 1034 
Confocal images were acquired with a LEICA SP5 microscope with a 405 nm laser, 1035 
an argon multiline (458-514 nm), a helium neon 561nm and a helium neon 633nm 1036 
laser. For quantification of stainings of vibratome sections we acquired tilescans from 1037 
the whole ventricle and z-stacks of 20 μm with 1 μm apart in a resolution of 1038 
2048x2048. For quantification of cryosections we acquired tilescans of the whole 1039 
ventricle combined with z-stacks covering the tissue thickness in a resolution of 1040 
1024x1024. Finally, for imaging of stained cells from in vitro cultures 6-12 fields of 1041 
view were obtained at a resolution of 512x512. For all images a 40x oil immersed 1042 
objective was used. Quantifications were performed with Fiji and the plug-in cell 1043 
counter navigating through the stacks. For quantification of TCF/Lef activity in 1044 
different domains, we measured the total length of the SVZ occupied by cells and 1045 
assigned the upper 1/3 as dorsal and the lower 2/3 as lateroventral. Highly 1046 
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autofluorescent speckles called lipofuscin were observed in the aging brain. Speckles 1047 
present in all fluorescent channels were visually excluded during quantifications. 1048 
Analysis of Smart-seq2 single-cell RNA-seq data  1049 
Sorting for Smart-seq2 1050 
Preparation was performed as described in (Llorens-Bobadilla et al., 2015). Briefly, 1051 
we sorted for CD45-O4-CD133+GLAST+ NSCs (Figure S6A). Single NSCs were 1052 
handpicked and libraries according to Smart-seq2 were prepared. 4 mice of 23 MO 1053 
were pulled per replicate. 1054 
In total, we performed RNA-seq on 145 old single cells in parallel with published data 1055 
from (Llorens-Bobadilla et al., 2015) which were used as young counterparts. All the 1056 
steps for cell sorting and library preparation were identical. Through quality control 1057 
steps, we removed 12 cells and kept 133 cells for downstream analysis. For isolation 1058 
of astrocytes, we sorted for GLAST+O4-CD45- from cortex or striatum, cells were 1059 
handpicked and libraries were prepared according to Smart-seq2 as previously 1060 
described in (Llorens-Bobadilla et al., 2015). 1061 
Quality control steps are described as following.  1062 
Smart-seq2 library preparation 1063 
Single cell RNA-seq libraries were prepared according to the Smart-seq2 protocol as 1064 
described by (Picelli et al., 2014). Single cells were pipetted in lysis buffer and were 1065 
frozen O/N. Subsequently, cells were thawed and reverse transcription was performed 1066 
with an oligo(dT) primer and a locked nucleic acid-containing template-switching 1067 
oligonucleotide. ERCC Spike-Ins (Ambion) were added to 8 randomly selected 1068 
samples at a dilution 1/1000000. Full-length cDNA was amplified with the KAPA 1069 
HiFi polymerase by 20 cycles of PCR. Samples with high quality of cDNA were 1070 
further processed after assessment on a High Sensitivity Bioanalyzer chip (Agilent). 1071 
Libraries for Illumina sequencing were generated with the Nextera XT Sample 1072 
preparation protocol after extending the tagmentation to 8 minutes and doing a double 1073 
bead clean up with 0.8X AMPure XP SPRI beads after PCR amplification of 9 cycles.  1074 
Read trimming and mapping  1075 
Raw read quality was checked by FASTQC 1076 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Trimming of adapter 1077 
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sequences in raw reads was performed before alignment with Btrim64 1078 
(http://graphics.med.yale.edu/trim) (Kong, 2011). Mapping of trimmed reads to the 1079 
mouse genome (ENSEMBL Release 78/GRCm38.p3) was done using STAR 2.4.0g 1080 
(Dobin et al., 2013). Mapping results to the genome were visually inspected with the 1081 
Integrative Genome Viewer (www.broadinstitute.org/igv/). 1082 
RNA-seq data quality metrics  1083 
RNA-seq data quality metrics of each cell, including total reads, transcriptome 1084 
mapped reads and transcriptome mapped rate was calculated by picard-tools-1.123 1085 
(https://broadinstitute.github.io/picard/) (Table S4).  1086 
Gene Expression Matrices  1087 
Gene expression matrices were generated as previously described (Shalek et al., 2014; 1088 
2013). Gene expression levels as transcripts per million (TPM) and fragments per 1089 
kilobase of transcript per million mapped reads (FPKM) were produced with RSEM 1090 
1.2.18 with default parameters. Additionaly, we used Trinity (Haas et al., 2013) 1091 
(http://trinityRNA-seq.github.io/) based on edgeR (Robinson and Oshlack, 2010) to 1092 
perform TMM (trimmed mean of M-values) an additional normalization on FPKM 1093 
(abbreviated TMM-FPKM), to be able to compare samples with differences in the 1094 
total cellular RNA production.  1095 
Quality control of single-cell RNA-seq data  1096 
The qualities of single cell RNA-seq libraries were checked by the combination 1097 
alignment rates and number of genes detected with TPM >1. Cells showing 1098 
substantially fewer numbers of genes detected (TPM >1) and/or lower mapping rates 1099 
(two times standard deviation) than others were filtered out. We also filtered out cells 1100 
in which Gapdh and Actb are lowly expressed (TPM <100) and Slc1a3-negative 1101 
NSCs (TPM <10). In total, 132 single cells passed quality control and were used in 1102 
downstream analysis.  1103 
ERCC spike-in controls  1104 
The quality of single-cell RNA-seq data was assessed by adding known amount of 92 1105 
ERCC spike-in RNA transcripts in 8 random cells and the expression levels of these 1106 
transcripts in TPM correlated well to the known amount.  1107 
Monocle pseudotime assignment 1108 
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The TPM values data from young and old cells were loaded together into the 1109 
monocle2 R package using its relative2abs function (Qiu et al., 2017). During the 1110 
creation of the CellDataSet object lowerDetectionLimit was set to 0.5 and a 1111 
negbinomial expression family was selected.  The ordering genes used for the 1112 
pseudotime calculation were selected based on a mean_expression >= 0.5 and 1113 
dispersion_empirical >= 3 * dispersion_fit. Pseudotime assignments for all cells were 1114 
saved into a file for later use. 1115 
Expression of DNA damage associated genes 1116 
To check for the expression of DNA damage associated genes in the data, a heatmap 1117 
was created using the pheatmap R package (version 1.0.8) from a list of manually 1118 
selected genes. The TPM values for those genes were log2 transformed before 1119 
plotting 1120 
PCA 1121 
PCA was run on the TPM values of the 2000 most variable genes in the dataset and 1122 
for all cells PC1 and PC2 were plotted against each other in a scatterplot. PCA plots 1123 
were also prepared for individual subpopulations and cells colored by age of the 1124 
animal. 1125 
DE analysis Smart-seq2  1126 
Differentially expressed genes between astrocytes and qNSC1 were determined using 1127 
a likelihood ratio test as described in (Llorens-Bobadilla et al., 2015). The log-1128 
transformed TPM gene expression values of the up and downregulated genes (>2 1129 
fold-change, adjusted p-value <0.1) from qNSC1, qNSC2 and astrocytes in the Smart-1130 
seq2 data were plotted as a heatmap (using pheatmap R package). 1131 
Differentially expressed genes of each activation state against all others were 1132 
determined by t-test as provided by Seurat. Differentially expressed genes between 1133 
cells from old and young mice within each activation state were determined by 1134 
DESeq2 after exclusion of non-expressed genes. In addition, we calculated 1135 
differentially expressed genes between cells from old vs. young mice within each 1136 
activation state by the difference of the mean log-transformed TPM expression values 1137 
divided by the mean SD and ranked by the nominal p-value (t-test). 1138 
Euclidean distance calculation 1139 
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The euclidean distances between neighbouring activation states along the neurogenic 1140 
lineage (qNSC1, qNSC2, aNSC1, aNSC2) between cells from 2 MO and 23 MO mice 1141 
within the same subpopulations were calculated on the first 5 principal components 1142 
and their distribution was plotted using density estimation (ggplot2 R package). 1143 
Bulk RNA sequencing 1144 
Bulk RNA seq 1145 
For Bulk sequencing we sorted 1000 events of different populations based on the 1146 
following marker combinations: Endothelial CD45-CD31+, Microglia 1147 
CD45+CD11b+, NSCs CD45-CD133+GLAST+, Neuroblasts CD45-GLAST-PSA-1148 
NCAM+ (Figure S6C). Since the CD31 epitope was sensitive to trypsin we did the 1149 
endothelial and microglia cell isolation with the Neural Tissue Dissociation kit 1150 
(papain). Briefly, RNA was isolated with arcturos pico pure kit and cDNA was 1151 
prepared using the SMARTer Ultra Low Input RNA for Illumina Sequencing – HV. 1152 
Finally, libraries were prepared for sequencing using the NEBNext Ultra DNA 1153 
Library Prep Kit for Illumina. 2 2 MO and 4 19 MO mice were pulled per replicate. 1154 
Processing RNA-seq data of bulk  1155 
We prepared biological duplicates of libraries from young and old populations from 1156 
NSCs, endothelial, microglial and neuroblast cell types. Quality control of cell 1157 
population RNA-seq data was performed as the single-cell RNA-seq data. After 1158 
quality control raw reads were mapped to the mouse reference genome GRCm38 1159 
(ENSEMBL release 78/ GRCm38.p3) using STAR_2.4.0g1. Genes annotated in 1160 
ENSEMBL release 78 were quantified with HTSeq 0.6.1p2. Differential expression 1161 
analysis was performed with DESeq2. 1162 
GO term enrichment analysis 1163 
The lists of differentially expressed genes from comparing old to young for NSCs, 1164 
neuroblasts, microglia, endothelial cells were filtered for those genes with an adjusted 1165 
p-value of less than 0.05 and then supplied to the clusterCompare and simplify 1166 
functions of the clusterProfiler R package (Yu et al., 2012) to prepare a dotplot of the 1167 
top 8 GO categories from each celltype using the “biological process” ontology. 1168 
Expression of Innate immune response genes 1169 
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Significantly upregulated genes in the comparisons of 19MO to 2MO samples for 1170 
each cell type were checked for annotation in the InnateDB and Ensembl gene IDs 1171 
were obtained using the biomaRt R package (version 2.32.1). The annotated genes 1172 
were highlighted on MA plots of the comparisons for the respective celltypes. In the 1173 
7MO to 2MO NSC MA plot the genes from the 19MO vs 2MO comparison were 1174 
highlighted. 1175 
10x Chromium 3′sequencing 1176 
Sorting for 10x Chromium 3′  1177 
Single cell suspension was prepared as described before. To ensure that there is 1178 
enough starting material for the Chromium 3’ 10x platform, we sorted CD45-O4-1179 
Ter119-GLAST+ (Figure S6B). 8000 FACS events underwent the downstream 1180 
process according to the manufacturer’s details. 4 2MO and 8 22 MO mice were 1181 
pulled for each library. 1182 
Library preparation, sequencing and mapping 1183 
We prepared one library from cells isolated from old and another with cells isolated 1184 
from young mice (both with 10x Genomics Chemistry: Single Cell 3' v2) and 1185 
sequenced them on a HiSeq 4K PE 100. The Cell Ranger Software (Ver. 2.0.0) 1186 
provided by 10x Genomics was used to map the reads (provided as fastq files) to the 1187 
mouse reference genome (ENSEMBL Release 78/GRCm38.p3) for each sample 1188 
individually and the two samples were merged according to the Cell Ranger manual. 1189 
Analysis with the Seurat package 1190 
The Seurat R package (version 2.2.0) was used for further inspection and data 1191 
analysis. First all genes, which showed expression in less than 3 cells were discarded. 1192 
Then the cells were filtered for further analysis based on the following parameters: 1193 
expression of at least 1500 genes and at most 4500 genes (to exclude cell duplets), 1194 
less than 10% of transcripts coming from mitochondrial genes. After these filters 1195 
3066 cells remained (out of 3937 cells initially provided by the CellRanger pipeline) 1196 
(Table S4). The transcript counts were log transformed, the number of detected genes, 1197 
number of detected unique molecular barcodes (UMIs) and the percentage of 1198 
mitochondrial gene expression was regressed out and transformation to z-scores was 1199 
performed, by subtraction of the mean and division by the standard deviation. As we 1200 
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compared cycling and non-cycling cells we aimed to reduce the influence of the cell 1201 
cycle states on cells from the same cell type, while keeping the cell cycle signal, 1202 
which is an important component of NSC activation. As described in the Seurat 1203 
package documentation, all cells were scored for the cell cycle states G1-, G2/M- and 1204 
S-phase and then the difference between the G2/M- and S-phase scores was regressed 1205 
out to discard the cell cycle states difference, while keeping the cell cycle signal. 1206 
Genes were determined to be variable based on the following parameters:  mean 1207 
expression between 0.0125 and 4 and log variance to mean ratio of at least 0.5. Those 1208 
variable genes were used as input for PCA. This dimensionally reduced data was used 1209 
for clustering using Seurat’s graph-based clustering approach with a resolution 1210 
parameter of 0.8, selecting the first 8 principal components as input. 18 cells were 1211 
excluded from the further analysis as they also showed expression of the leukocytic 1212 
marker gene PTPRC (CD45) or ependymal marker genes (Jacquet et al., 2009) and 1213 
thus are possibly contaminations of cells from these celltypes.  For visualisation t-1214 
SNE was run on the first 8 principal components. To check whether clusters were 1215 
separating based on the age of the animals and if there are batch effects, PCA and t-1216 
SNE plots were generated for all cells and individual subpopulations and cells were 1217 
colored according to the animal age (Figure 4C). Gene expression of individual 1218 
marker genes in the determined clusters was checked by coloring the cells in the t-1219 
SNE plot according to gene expression strength. The identity of the subpopulations 1220 
was determined by manual inspection of the gene expression values for previously 1221 
used marker genes and comparison of differentially expressed genes of each cluster 1222 
(compared to all the other clusters in the dataset). Those were compared to 1223 
differentially expressed genes from the Smart-seq2 single-cell RNA sequencing data 1224 
(Llorens-Bobadilla et al., 2015). The aNSC0 subpopulation is composed of two 1225 
clusters which showed a difference in the expression of immediate early response 1226 
genes, while the aNSC1 subpopulation contains two clusters showing a seperation 1227 
based on the predicted cell cycle phase. A phylogenetic tree based on average cells for 1228 
all determined identities was constructed based on the first 8 PCs using the 1229 
BuildClusterTree function. The average gene expression for all genes was calculated 1230 
between young and old cells in NSCs, cell types along the neurogenic lineage as well 1231 
as OPCs and ODs and plotted in a scatterplot with log10 transformed axes.  1232 
Monocle pseudotime assignment 1233 
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Raw transcript counts from the CellRanger output were also loaded into the monocle2 1234 
R package (version 2.4.0) and filtered to exclude cells identified as OD or OPCs. A 1235 
cellDataSet object was prepared as described for the Smart-seq2 sequencing data. The 1236 
ordering genes were selected to have a mean expression >= 0.6 and an empirical 1237 
dispersion >= 3 * dispersion fit. Pseudotime computation results were saved and used 1238 
together with the cluster identities from the Seurat clustering to check if the identified 1239 
clusters agree with the predicted pseudotime by plotting the identity-colored cells 1240 
according to their monocle predicted reduced dimensions dimensions and vice versa 1241 
coloring cells in the tSNE plot by their predicted pseudotime value. 1242 
DE and GO term enrichment analysis 1243 
To find differentially expressed genes between cell from 2 and 22 MO mice the 1244 
DESeq2 R package (version 1.16.1) was used. The clusterProfiler R package (version 1245 
3.4.4) was used for GO term enrichment analysis with its clusterCompare and 1246 
simplify functions using the “biological process” ontology. Genes with an adjusted p-1247 
value <0.05 and an absolute Fold Change >2 were used. Differentially expressed 1248 
genes of each activation state against all others were determined by t-test as provided 1249 
by Seurat. DE genes between cells from old and young mice within each activation 1250 
state were determined by DESeq2 as provided by Seurat. In addition, we calculated 1251 
differentially expressed genes between young vs. old cells within each activation state 1252 
by the difference of the mean log-transformed expression values divided by the mean 1253 
SD and ranked by the nominal p-value (t-test). 1254 
Euclidean distance calculation 1255 
The euclidean distances between neighbouring activation states along the neurogenic 1256 
lineage (qNSC1, qNSC2, aNSC0, aNSC1, aNSC2, TAP, NB) as well as between 1257 
qNSC1 and OD or between cells from 2MO and 22MO mice within the same 1258 
subpopulations were calculated on the first 8 principal components and their 1259 
distribution was plotted using density estimation (ggplot2 R package). 1260 
Statistics 1261 
Statistics were performed as indicated in each figure. All multiple comparisons 1262 
were performed with GraphPad Prism's one-way Anova function, which 1263 
also performs a Tukey-Kramer test, reporting p values adjusted to control family-wise 1264 
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error rate for the family comprising comparisons of each group against all other 1265 
groups. 1266 
Supplemental item titles 1267 
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Modeling the NSC Dynamics in the V-SVZ.  1269 
Data S2 Related to Figure 6 1270 
Markov chain-based computational method to identify niche determinants. 1271 
TableS1_DE Genes in Celltypes_10x_and_Smart-seq2 Related to Fig. 3, 4, S3 1272 
Lists of differentially expressed genes in each cluster when compared to all other 1273 
clusters from Smart-seq2 and Chromium Single cell 3’. Gene ontology analysis 1274 
included for each gene set. 1275 
TableS2_Diff. Expressed Genes Fig. 3 and 5 1276 
List of DE genes between 19 MO and 2 MO mice for NSCs, Neuroblasts, Endothelial 1277 
and Microglial cells. Also contains the list of DE genes from the comparison between 1278 
old qNSC1 vs old astrocytes from Smart-seq2 single cell RNAseq. Finally, contains 1279 
the list of DE genes, as calculated by DEseq2 or mean diff./SD from the comparison 1280 
of cells from old vs. young mice within each activation state, sequenced with Smart-1281 
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statistical significance, as that would incorrectly assume that each individual cell is an 1284 
independent sample. 1285 
TableS3_Subpopulation Specific Signaling Intermediates Related to Figure 6 1286 
Lists of signaling intermediates identified by the MCCM. 1287 
Table S4_scRNAseq Quality Metrics Related Fig. 3, 4 and STAR methods 1288 
RNAseq quality metrics of Bulk RNA seq and sc RNA sequencing with Smart-seq2 1289 
and 10x platforms. Also contains the number of cells per activation state for Smart-1290 
seq2 and 10x Chromium single cell. 1291 
 1292 
Figure1 Click here to access/download;Figure;Figure1.jpg
Figure2 Click here to access/download;Figure;Figure2.jpg
Figure3 Click here to access/download;Figure;Figure3.jpg
Figure4 Click here to access/download;Figure;Figure4.jpg
Figure5 Click here to access/download;Figure;Figure5.jpg
Figure6 Click here to access/download;Figure;Figure6.jpg
Modeling the Dynamics
of Neural Stem Cells
in the Subventricular Zone (SVZ)
1 Development of the model with constant rates
We set-up and analyze a model of cell population dynamics in the subventricular zone (SVZ),
capable of reproducing observed experimental data. The model accounts for dynamics of neu-
ral stem cells (NSCs) and progenitor cells. These dynamics have been experimentally ad-
dressed before, suggesting that NSCs exist in a quiescent or an active (dividing) state (Ponti
et al., 2013, Calzolari et al., 2015, Lim et al., 2016). Dividing NSCs produce progenitors via
symmetric divisions (Ponti et al., 2013, Lim et al., 2016) or undergo asymmetric divisions as
well as symmetric self-renewing divisions (Calzolari et al., 2015). Moreover, progenitors have
been observed to undergo 2-3 rounds of symmetric divisions (Ponti et al., 2013, Calzolari et
al., 2015, Lim et al., 2016).
Following that experimental evidence, we propose a mathematical model of NSCs in the
SVZ, in which quiescent NSCs (qNSCs) may enter the cell cycle to become active NSCs (aN-
SCs; Data S1-Fig.1.1). Active NSCs divide and become either two qNSCs or two progenitors
with the capacity of performing n symmetric self-renewing divisions. Taking into account the
two division modes of stem cells provides a minimal set of assumptions allowing, on one hand,
1
Data S1
to explain the age-related decline of NSC numbers, which has been observed in the data as well
as in previous studies (Shook et al., 2012, Capilla et al., 2014, Silva et al., 2016) and, on the
other hand, to fit the observation that NSCs that incorporated BrdU once become quiescent.
Both observations could be also explained by replacing the symmetric self-renewal divisions,
i.e. aNSC → 2 × qNSC by asymmetric divisions of the form aNSC → progenitor + qNSC,
or assuming co-existence of both types of divisions. Such assumptions lead to a similar model
and it can be shown mathematically that both models are equivalent (with a different defini-
tion of model parameters). Also, introducing additionally cell death rates for all cell types or
directly transitions of NSCs into a postmitotic non-neurogenic astrocyte would not change the
model dynamics (Stiehl and Marciniak-Czochra, 2011, Ziebell et al., 2017). In summary, the
model can be directly extended to account for fate possibilities different than symmetric divi-
sion such as asymmetric divisions, cell death or direct transitions into astrocytes what would
lead to an increase of the number of model parameters (hence a different quantification) but
would not affect the dynamical aspects which are behind model conclusions. Such scenario
has been considered recently in the model of hippocampal neurogenesis and showed consistent
dynamics (Ziebell et al., 2017). Taking it into account, in the reminder of this paper we con-
sider the model based on a minimal set of assumptions accounting for experimentally observed
types of divisions and cell transitions. A corresponding scheme representing rules of the stem
cell system is presented in Data S1-Fig.1.
Taken together, our model consists of the set of linear ordinary differential equations
d
dt qNSC(t) = −rqNSC(t) + 2bp
stemaNSC(t),
d
dt aNSC(t) = r qNSC(t)− p
stemaNSC(t),
d
dt progn(t) = −p
prog progn(t) + 2(1− b)pstem aNSC(t),
d
dt progk(t) = 2p
progprogk+1(t)− pprogprogk(t),
(1.1)
k ∈ {0, . . . , n− 1}, where r is the activation rate of qNSCs, pstem the division rate of NSCs, b
the probability of an aNSC to divide into two qNSCs versus two progenitors. The parameter
pprog denotes the division rate of progenitors and n ∈ N the total number of division rounds of








aNSC → 2× qNSC
b
aNSC → 2× progn
1− b
B
progn progn → 2× progn−1
pprog
progk progk → 2× progk−2
pprog
...
prog1 prog1 → 2× prog0
pprog
prog0 prog0 → 2× nblast
pprog
Data S1-Fig. 1: Graphical representation of the proposed model
(A) Quiescent neural stem cells (qNSCs) may enter the cell cycle at the rate r to become activated
NSCs (aNSC), which in turn divide at the rate pstem to either produce two qNSCs (with probability
b) or two progenitors (with probability 1 − b) with the capacity of n symmetric self-renewing
division (progn). (B) Progenitors with capacity of k symmetric self-renewing divisions (k =
1, . . . , n) divide at the rate pprog into two progenitors with capacity of k − 1 symmetric self-
renewing divisions and progenitors without this capacity (prog0) symmetrically divide into two
neuroblasts.
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Since we solely focus on the dynamics of NSCs, we follow a top-down approach in which
we start with a basic model which is capable of reconstructing the produced data. Thus, instead
of considering the hypothesis of Ponti et al, 2013, that progenitors perform 3 symmetric self-
renewing divisions followed by direct transformation into neuroblasts, we equivalently assume
that progenitors undergo n = 2 symmetric self-renewing divisions followed by symmetric
division into neuroblasts. These neuroblasts then enter the rostral migratory stream and move
away from the SVZ. This approach allows eliminating one model parameter (transformation
rate into neuroblasts) while maintaining the total number of progenitor division rounds.
2 Model quantification
The cell cycle dynamics of NSCs and progenitors were investigated in the study of Ponti et
al, 2013. Average cell cycle and S-phase lengths of both cell types have been measured as
tstemc = 17.5 h, tstems = 4.4 h, tprogc = 20.5 h and tprogs = 13.5 h. To compute the proliferation rate
of NSCs and progenitors, we interpret cell cycle lengths as doubling times of the corresponding




and pprog = log(2)
tprogc
. (2.1)
The remaining parameters r and b are estimated by fitting the model to data, consisting of
measurements of the number of NSCs (data in Fig.1), the relative frequency of the active cells
(Ki67+) as a fraction of the adult label-retaining cells and the relative frequency of the active
cells (2h BrdU) as a fraction of the TLX labelled cells. For a mathematical explanation of
how to simulate the relative frequency of active label-retaining cells, we refer the reader to
Section 5. Model fitting is obtained using the NonlinearModelFit procedure of Mathematica 9
to numerically minimize the weighted sum of squared residuals. Weights are chosen as inverse
squares of the standard deviation. The resulting fit of model (1.1) to the experimental data is
presented in Fig.1E.
To increase the number of data points used for model fitting, we consider a joint data set
consisting of the subset of the frequency of active cells as a fraction of the adult label-retaining
cells and of the subset of active cells as a fraction of the TLX labelled cells (data shown in
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Fig.S1 A-D, Fig.S5). We fit the model using both subsets simultaneously. In Section 6 we show
the fits that are obtained if the relative frequencies of subset 1 (active adult label-retaining cells)
only or subset 2 (active TLX labelled cells) only are used to represent the fraction of active
NSC. The results obtained based on the different data sets are consistent and lead to the same
conclusions.
3 Evaluation of the model with constant rates
Although the model with constant parameters reflects decay in the number of NSCs, we ob-
serve that it does not match the long time dynamics which exhibits a decay-saturation with age
(shown in Fig.1E in logarithmic scale). This result is in agreement with results obtained for
the model of hippocampal neurogenesis (Ziebell et al., 2017). To explore further discrepancy
between model (1.1) and experimental data, we observe that in a model with constant param-
eters given by system (1.1) the fraction of qNSCs to aNSCs converges rapidly to a constant
value. The limit limt→∞ qNSC(t)aNSC(t) can be calculated from a corresponding differential equation
for qNSC(t)aNSC (Ziebell et al., 2014). It yields that also the predicted relative frequency of the aN-
SCs as a fraction of all NSCs remains constant in time (Fig.1E), which does not match the data
exhibiting a decline of the respective fractions during aging. This observation motivates us to
search for mechanisms that can explain the age-related changes in stem cell dynamics.
4 Model of aging
Model (1.1) consists of 3 NSC related parameters, r, b and pstem. In order to investigate how
the dynamics of NSCs change during aging, we consider three scenarios, each related to a time-
depended change of one of the three parameters. Considering the different scenarios leads to
three models with time-dependent parameters, which are validated using the above described
different sets of experimental data. Parameter values obtained for the three fits are listed in
Data S1-Tables 1, 2 and 3 in Section 6 and corresponding plots are presented in Data S1-Fig.5
through Fig.15.
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4.1 Model with cell cycle lengthening
The first scenario, cell cycle lengthening, assumes that an aNSC takes on average progressively
longer to complete its cell cycle. Since the cell cycle length enters the model via formula (2.1),
its increase is modelled by decreasing in time the aNSC division rate (pstem) and cell cycle
lengthening is implemented using
pstem(t) = pstemmax e
−βpt.
Changing the cell division rate of aNSCs does not, however, change the dynamics of the
predicted relative frequency of the aNSCs as a fraction of all NSCs (see Fig.1F) which remains
constant in time. The best fit also does not exhibit the saturation observed in data (Fig.1F), since
the parameter estimation results in a very small value of βp.
4.2 Model with increasing self-renewal
The second scenario, increasing self-renewal, is based on the hypothesis that during aging, the
fraction of self-renewing aNSCs divisions increases, i.e., a higher fraction of divisions leads





1 + e−βbt(2bmin − 1)
)
.
The specific choice of the function b(t) is motivated by the observed decline of NSC counts
during aging, i.e. b(t) ≤ 1/2 must hold. The chosen function can be fitted to satisfy this
condition for any bmin ≤ 1/2.
The resulting increased production of qNSCs yields a slightly increased frequency of qN-
SCs as a fraction of all NSCs and consequently, a decrease in fraction of aNSCs of all NSCs.
However, the latter decline is very small (only 3.5%) not matching the decline observed in the
experimental data (Fig.1G) and, in particular, too small in young mice. Moreover, the resulting
dynamics involves a very rapid decline of aNSCs at young age. Following the dynamics of the
model for small times (time going back to zero), the model predicts a three order of magnitude
larger NSCs population at the initial time, i.e. around 1.1×106 NSCs at time zero, what seems
to be unrealistic (see Data S1-Fig.2).
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Data S1-Fig. 2: Fit of the neurogenesis model with increase of self-renewal during aging. The cell counts at age 0
are in the order of 106. The red curve corresponds to model simulations. Each black dot denotes
experimental data of one mouse.
7
4.3 Model with increasing quiescence
Finally, we model increasing quiescence by assuming that NSCs spend progressively longer
time in the qNSCs stage during aging. It is modelled using a time-declining activation rate,
r(t) = rmaxe
−βrt.
The resulting model describes well the relative frequency of aNSCs as a fraction of all NSCs
the decline of which provides the best fit to the data displayed in Fig.1H.
To further characterize the increasing quiescence scenario, we can compute the mean time a
NSC spends in quiescence during aging. The calculation is based on a corresponding stochastic
interpretation of the differential equation model and the property that a random variable, expo-
nentially distributed with parameter r, has mean 1/r. The resulting mean time in quiescence,
1/r(t), is displayed in Data S1-Fig.3.
4.4 Comparison of the fits: Model selection using Akaike
information criterion.
To substantiate our observations that only increasing quiescence can explain the data, we make
use of model selection theory by computing Akaike information criterion (AIC) weights for
each of the discussed scenarios (Data S1-Tables 1, 2 and 3). The level of empirical support of
a certain model is considered substantial if 0 ≤ ∆ ≤ 2, considerably less so if 4 ≤ ∆ ≤ 7
and none, if ∆ > 10 holds (Burnham and Anderson, 2002). The obtained Akaike weights
for all fitted models are displayed in Section 6. Thus, model selection theory also suggests
that only the increasing quiescence scenario, i.e. increasing the mean time a cell spends in the
quiescence, fits to the data.
4.5 Comparison of the fits: Model with two time-dependent
parameters.
To further validate our result and discriminate between the two age-dependent scenarios, we
consider a model combining the two time-dependent parameters describing increasing frac-
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Data S1-Fig. 3: Predicted mean time NSC spends in the quiescent phase depending on the age of the animal. The
prediction is based on the increasing quiescence scenario.
tion of self-renewal and increasing the mean time a cell spends in the quiescence, simultane-
ously. Obviously, increasing the number of free parameters allows finding a fit with a smaller
weighted sum of squared residuals; see Data S1-Fig.5, Fig.7 and Fig.12 compared in Data S1-
Fig.16. However, it is not a better fit in terms of the Akaike Information Criterion (AIC), which
measures goodness-of-fit taking into account the number of degrees of freedom involved. To
weight the contribution of time-dependent changes in the two parameters, we compare their
estimated dynamics; see Data S1-Fig.17. We see that the optimal fit of the model with two
time-dependent parameters resembles the scenario involving the time-dependent quiescence
only, i.e. it requires that the rate of activation from quiescence significantly decreases in time
and that the self-renewal fraction remains nearly constant in time (changing slightly only at
younger ages), while it is very different from the fit with only self-renewal increasing in time.
This comparison of the estimated cell properties shows that even if the two parameters undergo
age-dependent changes, it is the time-increasing quiescence (decreasing rate of activation from
quiescence) which is the major component of the regulatory process and allows explaining the
observed dynamics.
5 Fraction of active label-retaining cells
In order to simulate the fraction of active label-retaining cells, mathematical insights have to













Data S1-Fig. 4: Experimental protocol for the analysis of active label-retaining cells. Animals had access to BrdU-
dilluted drinking water for two weeks. Two weeks after stopping BrdU administration, animals
were sacrificed and label-retaining cells analyzed (data shown in Figs S1 C-D, Fig.S5)
BrdU in drinking water for two weeks followed by a two week waiting period before animal
sacrifice (Data S1-Fig.4).
At the time of sacrifice, the fraction of Ki67+BrdU+ cells among all BrdU+ cells is com-
prised of aNSCs and progenitors:
Ki67+BrdU+cells
BrdU+cells





Moreover, the ratio of aNSCs to qNSCs at the time of sacrifice mirrors the ratio of BrdU+
aNSCs to BrdU+ qNSCs at that time, since during the two week waiting period between
BrdU stop and sacrifice, a quasi steady-state among BrdU+ cells is achieved:
BrdU+aNSC
BrdU+qNSC
(t = t†) =
aNSC
qNSC
(t = t†). (5.2)
Putting (5.1) and (5.2) together, we obtain
Ki67+BrdU+cells
BrdU+cells












Thus, in order to compute the fraction of Ki67+ cells among all BrdU+ cells at the time of
sacrifice, we need to compute BrdU+prog
BrdU+qNSC
(t = t†), since the ratio aNSC
qNSC
(t = t†) can be obtained
from the solution of the differential equation model (1.1). The ratio BrdU+prog
BrdU+qNSC
(t = t†) cannot
be obtained from the differential equation. The reason is that any progn cell being produced
prior to the time point t = t† − (n+ 2)tprogc would have already become a neuroblast at t = t†,
but according to the differential equation, a large number of progn cells being born prior to t =
t† − (n+ 2)tprogc would remain at t = t†. Individual-based behavior involving a deterministic
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conversion of one cell type to another after a fixed amount of time cannot be simulated in the
framework of differential equations. However, the ratio BrdU+prog
BrdU+qNSC
(t = t†) can be evaluated
as follows:
BrdU+ progenitors at the time of sacrifice can only originate from BrdU+ qNSCs that
exist at the time where BrdU is stopped being added to the drinking water, because any qNSCs
becoming activated at an earlier time would lead to progenitors that, at the time of sacrifice,
would already have become neuroblasts that migrated away from the SVZ. If a qNSCs existing
at the time of discontinuing BrdU becomes an aNSCs at a time between t = t† − (n + 1 −
k)tprogc − tstemc and t = t†− (n−k)tprogc − tstemc (k = 0, . . . , n), then one tstemc later, this aNSC
gives rise to two prog0 cells with probability 1 − b and a further (n − k) tprogc later, 2 · 2n−k
progk progenitors exist at a time between t = t† − tprogc and t = t†. This reasoning can be
summarized as follows:
• t(BrdU+qNSC → BrdU+aNSC) ∈ [t†− (n+1−k)tprogc − tstemc , t†− (n−k)tprogc −
tstemc ]
⇒ t(birth of 2prog0) ∈ [t† − (n+ 1− k)tprogc , t† − (n− k)tprogc ] w. prob. (1− b)
⇒ t(birth of 2n−k+1progk) ∈ [t† − tprogc , t†] w. prob. (1− b)
Let P(x) denote the probability of event x. It holds
P
(
t(BrdU+qNSC → BrdU+aNSC) ∈ [t† − (n+ 1− k)tprogc − tstemc , t† − (n− k)t
prog














This equality holds because, as explained above, the time until a qNSCs becomes an aNSCs is
exponentially distributed with parameter r and it holds that
P(X ∈ [t1, t2] | X ∼ exp(r)) = e−rt1 − e−rt2 .
The expected number of BrdU+ stem cell activations in the time interval










































In the following we present the detailed results of the model fitting. In Section 6.1 we combine
the experimental data of active cells among TLX+ cells with the experimental data of active
cells among label-retaining cells. This is motivated by taking into account that both experi-
mental approaches target the same cell population and it results in an increased number of data
points for the fraction of active NSC. In Section 6.2 we repeat the fitting using solely the frac-
tion of active among label-retaining cells to represent the fraction of active NSC. In Section
6.3 we repeat the fitting using solely the fraction of active among TLX+ cells to represent the
fraction of active NSC.
6.1 Joined dataset
In this Section we combine the experimental data of active cells among TLX+ cells with the
experimental data of active cells among label-retaining cells to increase the number of data
points (data shown in Fig.S1 A-D, Fig.S5). Data S1-Table 1 summarizes parameter values
and statistical quantities obtained from the fitting of the different model versions. The fits of
the neurogenesis model obtained assuming no aging, cell cycle lengthening, increasing self-
renewal or increasing quiescence are depicted in Fig.1 E-H of the main text. The fit obtained
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if we assume simultaneous increase of quiescence and self-renewal during aging is shown in
Data S1-Fig.5.
Mechanism Parameters R2 ∆AICc
Increasing  quiescence  and
self-renewal
rmax = 0.445 d
−1
βr = 9.2 · 10−4 d−1
bmin = 0.489
βb = 0.0022 d
−1
0.9758 0
Increasing quiescence rmax = 0.453 d−1
βr = 9.5 · 10−4 d−1
b = 0.494
0.9722 1.3
Increasing self-renewal r = 0.280 d−1
bmin = 0.0049
βb = 0.0276 d
−1
0.9537 16.7
No aging r = 0.278 d−1
b = 0.489
0.9468 18.1
Cell cycle lengthening r = 0.292 d−1
b = 0.489
pmax = 0.996 d
−1
βp = 1.1 · 10−9 d−1
0.9468 23.7
Data S1-Table 1: Summary of fitting results. We have combined the experimental data of active among TLX+
cells and active among label-retaining cells to quantify the fraction of active NSC.
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increasing quiescence and self-renewal

















































Data S1-Fig. 5: Fit of the neurogenesis model with increase of quiescence and self-renewal during aging. The
red curves correspond to model simulations. Each black dot denotes experimental data of one
mouse. We have combined the experimental data of active among TLX+ cells and active among
label-retaining cells to quantify the fraction of active NSC.
6.2 LRC data
In this Section we use the fraction of active cells among label-retaining cells to quantify the
fraction of active NSC (data shown in Fig.S1 C-D, Fig.S5). Data S1-Table 2 summarizes
parameter values and statistical quantities obtained from the fitting of the different models.
The different fits are depicted in Data S1-Fig.6 to Fig.10.
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Mechanism Parameters R2 ∆AICc
Increasing quiescence rmax = 0.407 d−1
βr = 8.1 · 10−4 d−1
b = 0.492
0.9928 0
Increasing  quiescence  and
self-renewal
rmax = 0.401 d
−1
βr = 7.8 · 10−4 d−1
bmin = 0.488
βb = 0.0023 d
−1
0.9940 0.1
Increasing self-renewal r = 0.246 d−1
bmin = 7.6 · 10−6
βb = 0.025 d
−1
0.9897 7.8
No aging r = 0.243 d−1
b = 0.488
0.9880 7.8
Cell cycle lengthening r = 0.235 d−1
b = 0.487
pmax = 0.919 d
−1
βp = 3.1 · 10−8 d−1
0.9880 14.4
Data S1-Table 2: Summary of fitting results. We have used the experimental data of active among label-retaining




















































Data S1-Fig. 6: Fit of the neurogenesis model with increase of quiescence during aging. The red curves corre-
spond to model simulations. Each black dot denotes experimental data of one mouse. We have
used the experimental data of active among label-retaining cells to quantify the fraction of active
NSC.
increasing quiescence and self-renewal

















































Data S1-Fig. 7: Fit of the neurogenesis model with increase of quiescence and self-renewal during aging. The
red curves correspond to model simulations. Each black dot denotes experimental data of one
mouse. We have used the experimental data of active among label-retaining cells to quantify the




















































Data S1-Fig. 8: Fit of the neurogenesis model with increase of self-renewal during aging. The red curves corre-
spond to model simulations. Each black dot denotes experimental data of one mouse. We have



















































Data S1-Fig. 9: Fit of the neurogenesis model without aging. The red curves correspond to model simulations.
Each black dot denotes experimental data of one mouse. We have used the experimental data of




















































Data S1-Fig. 10: Fit of the neurogenesis model with increase of cell cycle length during aging. The red curves
correspond to model simulations. Each black dot denotes experimental data of one mouse. We
have used the experimental data of active among label-retaining cells to quantify the fraction of
active NSC.
6.3 TLX data
In this Section we use the fraction of active cells among TLX+ cells to quantify the fraction
of active NSC (data shown in Fig.S1 A-B, Fig.S5). Data S1-Table 3 summarizes parameter
values and statistical quantities obtained from the fitting of the different models. The different
fits are depicted in Data S1-Fig.11 to Fig.15.
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Mechanism Parameters R2 ∆AICc
Increasing quiescence rmax = 0.440 d−1
βr = 9.3 · 10−4 d−1
b = 0.494
0.9937 0
Increasing  quiescence  and
self-renewal
rmax = 0.436 d
−1
βr = 8.9 · 10−4 d−1
bmin = 0.492
βb = 0.001 d
−1
0.9939 3
Increasing self-renewal r = 0.352 d−1
bmin = 0.093
βb = 0.028 d
−1
0.9895 10.8
No aging r = 0.350 d−1
b = 0.490
0.9879 10.8
Cell cycle lengthening r = 0.260 d−1
b = 0.487
pmax = 0.706 d
−1
βp = 6.7 · 10−10 d−1
0.9879 17.4
Data S1-Table 3: Summary of fitting results. We have used the experimental data of active among TLX+ cells to
















































Data S1-Fig. 11: Fit of the neurogenesis model with increase of quiescence during aging. The red curves corre-
spond to model simulations. Each black dot denotes experimental data of one mouse. We have
used the experimental data of active among TLX+ cells to quantify the fraction of active NSC.
increasing quiescence and self-renewal













































Data S1-Fig. 12: Fit of the neurogenesis model with increase of quiescence and self-renewal during aging. The
red curves correspond to model simulations. Each black dot denotes experimental data of one

















































Data S1-Fig. 13: Fit of the neurogenesis model with increase of self-renewal during aging. The red curves corre-
spond to model simulations. Each black dot denotes experimental data of one mouse. We have














































Data S1-Fig. 14: Fit of the neurogenesis model without aging. The red curves correspond to model simulations.
Each black dot denotes experimental data of one mouse. We have used the experimental data of
















































Data S1-Fig. 15: Fit of the neurogenesis model with increase of cell cycle length during aging. The red curves
correspond to model simulations. Each black dot denotes experimental data of one mouse. We
have used the experimental data of active among TLX+ cells to quantify the fraction of active
NSC.
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Data S1-Fig. 16: Comparison of the two single time-dependent parameter fits (upper panel) with a fit for a model
with two time-dependent parameters (lower panel).
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Data S1-Fig. 17: Comparison of the time course of two cell parameters (self-renewal fraction and activation rate)
in models with only increasing self-renewal (upper panel left) or only increasing quiescence
(upper panel right) versus the model with the two parameters increasing (lower panel).
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Markov chain-based computational method to identify 
niche determinants: 
Rationale: 
Stem cell-niche interactions involve several diverse and stochastically fluctuating components 
mediated by different supportive stromal cells, secreted molecules, physical factors such as 
oxygen tension, shear stress and temperature (Rezza et al., 2014). Such multifactorial 
complexity of stem cell-niche interactions is a major roadblock in identifying regulatory 
factors that determine the functional state of the stem cells. Some of these limitations can be 
overcome by considering that stem cells robustly maintain their state due to a constant effect 
created by the niche by integrating its signals via signaling pathways (Ravichandran and Del 
Sol, 2017). Accordingly, a constant niche effect should induce sustained activation/inhibition 
of specific stem cell signaling pathways in most of the cells within heterogeneous populations 
exhibiting the same phenotype (niche determinants) (Ravichandran and Del Sol, 2017). This 
view of stem cell-niche interactions shifts the focus of the problem towards the constant niche 
effect on key stem cell signaling, instead of accounting for niche composition and its 
interaction with the stem cells explicitly. Based on this rationale, we propose a novel 
computational method relying on a Markov chain model of signal transduction for the 
identification of niche determinants. The method represents a novel way to model sustained 
signaling mediated by the niche by considering that once the signal from the niche reaches 
downstream transcription factors, it starts again from the niche in an iterative manner, 
consequently producing a sustained signal transduction.  
Method description: 
In this modeling framework, signal transduction from the niche to intracellular signaling 
pathways is modeled as a Markov chain. Here, the signal is represented by a token that moves 
from one node to another (nodes denote the states of the Markov chain), solely depending on 
the transition probabilities calculated from experimental data. As depicted in Data S2- Fig. 
1A, if the token is at the niche, in the next time step, it can move to any of the three receptor 
nodes (1, 2 or 3). Further, at each time step, the token moves from the current node to the next 
node, and eventually reaches the downstream transcription factors. Once the token reaches 
any of the transcription factor nodes (11 or 12), it starts again to propagate down from the 
niche (Data S2- Fig. 1). Such a continuous propagation of the token simulates sustained 
Data S2
signaling. Importantly, the stationary probability distribution of the Markov chain provides 
the steady state probability of a node to contain the token. Those nodes that have high steady 
state probabilities are more likely to mediate the sustained signal transmission. We have 
proposed such a Markov-chain model for sustained signal transmission based on the analogy 
of a token travelling from the receptors to the TFs an infinite number of times. In other words, 
the token advances from one signaling molecule to the next with certain probability, that is 
determined by network topology and gene expression of the interacting molecules, and when 
it reaches a TF it starts again from the niche node. This process can be represented by 
including a feedback loop from the TFs to the niche node, and therefore the stationary 
probability distribution of this Markov chain should give the probability for each node to 
contain the token. In this model, high probability nodes are more likely to mediate the niche 
induced sustained signal. In addition, the presence of the feedback loop ensures that the 
stationary distribution does not have all probabilities in the TFs. However, this is a strategy to 
model the sustained signaling, rather than a biological feedback regulation of the niche by the 
transcription factors. The steps involved in the computational method are depicted in Data S2- 
Fig. 2 and an illustrative example of the method is shown in Fig. 6A.  
Method assumptions: 
The method considers that transcript levels measured from sequencing can serve as a 
surrogate for protein level of the respective gene. Although mRNA levels need not entirely 
reflect the protein levels due to several other post transcriptional regulatory mechanisms, we 
believe this assumption is reasonable since we are specifically interested in identifying 
constantly activated/inhibited signaling intermediates whose steady state protein levels are 
more likely to have high correlation with the respective steady state mRNA levels (Liu et al., 
2016).  
Construction of signaling interactome: 
We combined ReactomeFI (https://reactome.org) and Omnipath (http://omnipathdb.org/) 
databases and used the resulting compilation as the signaling interactome for our method. 
These two databases were chosen because they contain information from several other 
resources and have information of directionality of signal flow and regulatory nature of the 
interaction. This network consisted of 89444 edges and 5823 nodes.  In order to account for 
the niche influence on the intracellular signaling, we introduced an external niche-node, 
which we connect to all receptors and ligands in the signaling interactome (Data S2- Fig. 1B). 
Since a complete database of receptor/ligand molecules is currently unavailable, to compile a 
list of receptors/ligands we used Gene Ontology classification of receptor activity and plasma 
membrane (GO:0004872, GO:0005886) to identify genes with possible receptor activity. 
Further, in order to model the sustained signaling, we consider that once the signal reaches the 
transcription factors, it starts once again from the external niche-node. To achieve this, we 
connected all the transcription factor nodes in the signaling interactome to the external niche-
node (Data S2- Fig. 1B). This will ensures a continuous signal transmission from the niche to 
the transcriptions factors via signaling intermediates. We defined genes as transcription 
factors/regulators based on the annotation available at Animal TFDB 
(http://bioinfo.life.hust.edu.cn/AnimalTFDB/). Finally, we removed those nodes that had zero 
in-degree if they are not a receptor or a ligand and zero out-degree if they are not a 
transcription factor, as these nodes will not contribute to sustained signal transduction. After 
filtering for these nodes, the final network consisted of 5299 nodes and 87907 edges. 
Model formulation: 
We model the signal transduction from the niche to intracellular signaling pathways as a finite 
discrete time-homogenous Markov chain, where the signal originates from the niche and 
propagates successively via a finite set of signaling molecules S = {S1, S2, . . . , SN}. The 
probability of the signal to propagate from a molecule to another at successive time steps is 
given by 
! ! !!!! = !! ! !! = !! ,! !!!! = !! ,…! !! = !! = ! ! !!!! = !! ! !! !! = !! = !!" 
Accordingly, if the signal is currently in the molecule Si, the probability of it propagating to 
molecule Sj at the next time step depends only on where the signal is present in the current 
time step and not on previous time steps. Here, pij is the transition probability of the signal to 
propagate from molecule Si to Sj, defined by the transition probability matrix P obtained from 
the single-cell gene expression data.  
Sustained signal transmission is modeled by considering that, once the signal reaches a 
transcription factor, it is transmitted back to the external niche-node. Since the external niche-
node is connected to all receptors and ligands, such a transmission of signal back to niche-
node ensures that the signal continuously propagates from the niche to the transcription 
factors via the signaling intermediates (Data S2- Fig. 1B and Fig. 6A). Further, this ensures 
that the signaling interactome forms a strongly connected graph where one can reach any 
node from any other node via a directed path. Consequently, this Markov chain is irreducible 
(since the signaling interactome forms a graph with a single strongly connected component) 
and positive recurrent (since it is irreducible and finite).  
State transition probability matrix: 
For the construction of the state transition probability matrix, we rely on the mass action 
principle, where we assume that the probability of interaction among two nodes is 
proportional to the product of the expression values of the corresponding genes. This implies, 
!!" !∝ !!!!!  





where, !!  denotes the set of neighboring molecules regulated by Si and, !!" denotes the 
interaction weights defined by  
 !!" = !!●!! !, 
where, Ei and Ej are single cell gene expression vectors for the corresponding genes and !!" is 
calculated by the dot product (or the scalar product) of the two vectors.  
The signaling interactome serves as the topology and determines the interactions for which 
the transition probabilities are calculated. Therefore, in the transition probability matrix P, 
only those interactions present in the signaling interactome will have a non-zero transition 
probability calculated from the data and other will have zero probabilities. Further, it should 
be noted that the matrix P is a stochastic matrix.  
Single cell expression data generated using SmartSeq2 protocol was used as input for the 
method to calculate the interaction weights. Further, a gene was considered expressed if it had 
an FPKM >1 in that cell.  
Signal transmission from one molecule to another will depend on their interaction probability 
derived from single-cell RNA-seq data. For each cellular subpopulation, the interaction 
probability for any two molecules in the signaling interactome is proportional to the dot 
product of their expression vectors within the subpopulation. Hence, this probability will be 
high only when both the molecules are highly expressed in the same cell and expressed in a 
large number of cells for that subpopulation.  
Further, as an independent measure to remove interactions that occur in very few cells, 
interactions among two intermediates are considered to be present only if both the genes are 
simultaneously expressed in at least 20% of the cells (i.e. both genes must be expressed in the 
same cell and in at least 20% of the cells) else the specific interaction is removed from the 
network.  
Stationary distribution: 
An irreducible, positive recurrent Markov chain has a unique stationary distribution (Stewart, 
1994). Once the transition probability matrix is defined, the stationary distribution π of the 
stochastic matrix P (π P = π), (i.e. the left eigenvector with unit eigenvalue of P) is calculated 
by finding the eigenvector of transpose of transition probability matrix Pt with eigenvalue 
equal to 1 (Stewart, 1994). This distribution gives the steady state probability distribution of 
where the signal will be present at any given time instant.  
Convergence to a unique stationary distribution 
A finite, irreducible, and aperiodic Markov chain is ergodic, i.e. it has a unique stationary 
distribution which is equal to the Markov chain’s limiting distribution irrespective of the 
initial conditions (or probability distributions) (Stewart, 1994). We have verified that our 
construction results in an aperiodic Markov chain. We performed this by considering the 
lengths of all simple cycles measuring the shortest path lengths from the niche-node and 
found that the cycle lengths varied from 3 to 7. This ensures that the period of the niche-node, 
which is defined as the greatest common divisor of all its simple cycles, is 1 because all 
transcription factors are directly connected to the niche-node. This proves that the Markov 
chain is aperiodic.  
Identification of subpopulation specific signaling intermediates:  
Based on the method described above, steady state probability distributions for different cell 
subpopulations in young and old mice are calculated. First, a comparison of these 
probabilities is made within young or old neural stem cell subpopulations. This will identify 
those intermediates that are unique to each subpopulation for either young or old mice.  As a 
second step, the resulting list was used for a comparison between young and old mice to 
identify factors uniquely responsible for the maintenance of the quiescent or active 
subpopulations in either young or old mice. Table S3 lists the molecules identified for each of 
the subpopulations in young and old mice. Data S2- Fig. 3 shows the strategy used to shortlist 
the potential niche determinants for quiescent neural stem cells for old mice. 
Analyzing the role of key interactions for the observed steady state distributions: 
After calculating the stationary distribution based on the Markov chain, we were interested in 
contribution of individual interactions for the obtained stationary distribution. For this, we 
converted the original signaling interactome into a line graph where each node in the line 
graph is an edge of the original signaling interactome (Data S2- Fig. 4). Product of weights of 
two edges that interact were used for constructing the transition probability matrix of the line 
graph. We calculated the stationary distribution of the line graph as mentioned above. This 
probability distribution denotes the likelihood of an interaction to occur for a given single cell 
expression data. This information was used to identify the specific interactions uniquely 
present or absent in old quiescent NSCs when compared to the young ones.  
 
Data S2 Figure legends 
Data S2- Fig. 1 
Panel A: Representation of signaling as a moving token. The figure depicts the rationale 
behind the Markov chain model of sustained signaling. The signal is modelled as a token that 
moves in the Markov chain (signaling interactome) and is considered to start from the niche 
and propagate down to the transcription factors. Once the token reaches any of the 
transcription factor it starts once again from the niche. Such a continuously moving token 
simulates a sustained signaling from the niche.  
Panel B: A simple representation of the structure of the Markov chain model of the signaling 
interactome. The niche-node is connected to all the receptors/ligands and the transcription 
factors are connected to the niche. These two edges are shown in red color. The green edges 
are the ones directly obtained from the combined Reactome and Omnipath database. 
Data S2- Fig. 2 
Schematic of the steps involved in the computational method for the identification of niche 
determinants.  
Data S2- Fig. 3 
Schematic of strategy employed to identify niche determinants specific for quiescent neural 
stem cells in old mice. 
Data S2- Fig. 4 
Schematic of transformation of a normal graph into a line graph 
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